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ABSTRACT 
The research discussed within involves the development of novel applications of real­
time imaging of adenosine 5"-triphosphate (ATP). ATP was detected via bioluminescence 
from the firefly luciferase-catalyzed reaction of ATP and luciferin. The use of a microscope 
and an imaging detector allowed for spatially resolved quantitation of ATP release. 
Employing this method, applications in both biological and chemical systems were 
developed. 
First, the mechanism by which the compound 48/80 induces release of ATP from 
human umbilical vein endothelial cells (HUVECs) was investigated. Numerous enzyme 
activators and inhibitors were utilized to probe the second messenger systems involved in 
release. Compound 48/80 activated a Gq-type protein to initiate ATP release from HUVECs. 
Ca2+ imaging along with ATP imaging revealed that activation of phospholipase C and 
induction of intracellular Ca2+ signaling were necessary for release of ATP. Furthermore, 
activation of protein kinase C inhibited the activity of phospholipase C and thus decreased 
the magnitude of ATP release. This novel release mechanism was compared to the existing 
theories of extracellular release of ATP. 
Bioluminescence imaging was also employed to examine the role of ATP in the field 
of neuroscience. The central nervous system (CNS) was dissected from the freshwater snail 
Lymnaea stagnai is. Electrophysiological experiments demonstrated that the neurons of the 
Lymnaea were not damaged by any of the components of the imaging solution. ATP was 
continuously released by the ganglia of the CNS for over eight hours and varied from 
ganglion to ganglion and within individual ganglia. Addition of the neurotransmitters K+ and 
serotonin increased release of ATP in certain regions of the Lymnaea CNS. 
vii 
Finally, the ATP imaging technique was investigated for the study of drug release 
systems. MCM-41-type mesoporous nanospheres were loaded with ATP and end-capped 
with mercaptoethanol functionalized CdS nanocrystals. Aggregates of nanospheres were 
bathed in imaging solution, and ATP bioluminescence was monitored to investigate the 
release kinetics of the nanosphere drug delivery systems. Addition of disulfide bond-
cleaving molecules induced uncapping of the nanospheres and subsequently, the release of 
ATP. Increasing the concentration of the uncapping molecule decreased the temporal 
maximum and increased the magnitude of release of encapsulated ATP from the 
nanospheres. Furthermore, the release kinetics from the nanospheres varied with the size of 
the particle aggregates. 
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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation begins with a general introduction to the fields pertinent to the research 
presented within. The subsequent chapters are presented as three complete scientific 
manuscripts including all relevant supporting material. The final chapter contains general 
conclusions and future aspirations for the work discussed throughout. 
Overview 
As science evolves into the twenty-first century, the divisions between the fields of 
chemistry, biochemistry, and biology have become indistinguishable. Moreover, there is an 
ever-increasing interdependence among scientists from each of these fields. This is 
exemplified in the study of adenosine 5'-triphosphate (ATP). In this chapter, an overview of 
ATP, its metabolic functions, and its role as a cellular messenger are presented. Following 
which, a brief discussion of fluorescence microscopy instrumentation and applications is 
undertaken. Finally, the application of fluorescence microscopy to the study of ATP is 
discussed. 
ATP 
Discovery 
ATP was first identified in 1929 by two research groups independently: by Fiske and 
Subbarow in the United States1 and by Lohmann in Germany2. The structure of ATP was 
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elucidated three years later3. In that same year, Lohmann and Meyerhoff estimated the 
energy involved in the breakdown of the rich phosphate-anhydride linkages of ATP4. Further 
studies revealed that ATP was a product of glycolysis5, and thus, the central role of ATP in 
metabolism began to take shape. In 1941, Lipmann hypothesized that ATP was the primary 
molecule for chemical energy storage and proposed a cycle of ATP production and 
utilization existed within the cell6. In the years that followed, the theories of Lohmann and 
Lipmann became widely accepted, and the roles of ATP cellular function was solidified. 
Functions of ATP 
ATP serves numerous vital functions in the cell. First and foremost, it is the central molecule 
in metabolism. Molecules used as energy sources, for instance glucose, are broken down in 
the cell, and the energy obtained from them is stored in the phosphate-anhydride bonds of 
ATP7. For example, ATP is created via phosphorylation of adenosine 5"-diphosphate (ADP) 
in glycolysis. In the Kreb's cycle, guanosine 5'-triphosphate (OTP), which is 
interchangeable with ATP (see below), is synthesized from guanosine 5'-diphosphate. 
Furthermore, nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide 
(FADH2) are formed in the Kreb's cycle. These molecules are oxidized in the mitochondria. 
The energy from their oxidation is used to establish a proton gradient across the inner 
mitochondrial membrane. The primary role of this gradient is to drive the synthesis of ATP 
by ATP synthase. A similar mechanism is employed in the photosynthetic pathway to couple 
absorption of light to the synthesis of ATP8. The synthesized pool of cellular ATP is utilized 
to energetically drive numerous cellular processes. For example, the majority of 
phosphorylation reactions, which are catalyzed by kinases, use ATP as the phosphate donor. 
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Additionally, ion and molecule transport occurs against charge and concentration gradients 
through ATPase enzymes, using the breakdown of ATP to ADP and phosphate as the driving 
force. These generated gradients are used for second messenger signaling (Ca2+) and 
neurotransmission (K+ and Na+) among other cellular processes7. 
In addition to its role in metabolism, ATP also maintains the proper concentrations of other 
nucleotides (NTPs). ATP is interchanged into the other NTPs, which are incorporated into 
DNA and RNA. Furthermore, NTPs serve other imperative functions in cellular 
homeostasis. For example, GTP couples the activation of many receptors to their induced 
cellular effects via G-proteins. A third function of ATP is its involvement in various cellular 
syntheses as a reactant. It is directly incorporated into RNA by RNA polymerases. For 
synthesis of DNA, ATP is converted to deoxy-ATP prior to incorporation by DNA 
polymerases. The adenosine of ATP is also incorporated into a number of coenzymes, 
including FADH2, adenosine-3-cyclic monophosphate, NADU, and nicotinamide adenine 
dinucleotide phosphate7. 
ATP as a cellular messenger 
In the same year that ATP was discovered, Drury and Szent-Gyorgyi reported that 
extracellular ATP had drastic effects in the cardiovascular system9. Throughout the next 50 
years, the consequences of extracellular ATP application on numerous cell types were 
studied. While the majority of these effects were attributed to adenosine10 and adenosine 5'-
monophosphate (AMP)11, by 1972 the distinct consequences of extracellular addition of 
ATP, ADP, AMP, and adenosine had been established12. 
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In 1978, Burnstock established nomenclature for distinguishing adenosine and ATP 
receptors13. Adenosine receptors were termed PI purinergic receptors; four of these 
receptors have been identified to date. P2 purinergic receptors, which are the ATP and ADP 
sensitive receptors, are more numerous and diverse than the PI type. In 1994, Abbracchio 
and Burnstock classified P2 purinergic receptors into P2X and P2Y subtypes14. P2X 
receptors are ligand-gated ion channel receptors, while P2Y receptors are G protein coupled 
receptors. Seven P2X and six P2Y receptors have been identified and characterized to date. 
P2X receptors have been identified mainly in neurons and muscle cells. They respond to nM 
- |xM concentrations of ATP directly activating depolarizing currents. A few other general 
trends have been recognized for P2X receptors: 1) they have little selectivity for the various 
monovalent cations, and 2) they are activated and inactivated on the order of milliseconds. 
P2Y receptors, conversely, are quite diverse in both the effect of their activation and the 
agonists to which they respond. The P2Y receptors are classified further into their subtypes 
based on their response to various agonists, including ATP, ADP, their derivatives, and even 
the pyrimidine nucleotide UTP15. Today, they are being reclassified based on their protein 
sequences16. P2Y receptors have been identified in nearly every type of cell investigated (see 
reference 15 for a thorough listing). Activation of the receptors initiates numerous 
intracellular signaling pathways. All P2Y receptors have been linked to generation of 
intracellular Ca2+ increases via activation of phospholipase C (PLC). Increased Ca2+ levels 
initiate numerous cellular functions, most notably exocytosis and smooth muscle contraction. 
Secondary consequences of ATP stimulation of PLC include activation of protein kinase C 
and phospholipase A% and production of nitric oxide. Various P2Y receptor subtypes are 
reportedly also associated with inhibition of adenylate cyclase, which catalyzes production of 
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cAMP. Alternatively, the P2Yn has been linked to activation of adenylate cyclase and 
therefore production of cAMP17. cAMP controls various cellular processes by signaling for 
the phosphorylation and dephosphorylation of numerous enzymes. For example, cAMP 
controls the cellular production and breakdown of glycogen8. Numerous other pathways 
have been linked to P2Y receptor activation and are discussed in ref 17. 
Detection of ATP 
The actions of extracellular ATP on cells have been widely documented, as have the 
presence of the receptors that initiate them. However, the source of ATP release in vivo has 
remained less clear. This likely stems from the lack of suitable methods for monitoring real­
time release of ATP on a single cell level. Several methods for detection of ATP have been 
developed utilizing high performance liquid chromatography (HPLC)18"21. Both intracellular 
and extracellular ATP levels can be detected via lysis or direct sampling of extracellular 
solution, respectively. Other less common methods for detection of ATP include 32P 
"2 1 0*5 0/1 
radioactivity assays , P NMR " , enzyme-coupled fluorescence assays for flow injection 
analysis25, atomic force microscopy26, and patch clamp studies employing a mutant ATP-
sensitive K+ channel27. 
Bioluminescent Detection of ATP 
The most common method for the detection of ATP is via the luciferase bioluminescence 
assay. The reaction employed in the assay is catalyzed by the firefly (Photinus pyralis) 
enzyme luciferase and is shown below. 
6 
luciferin + ATP + 0% ^ AMP + PP, + CO2 + oxyluciferin* 
oxyluciferin* —> oxyluciferin + hv (562 nm) 
Along with luciferase, Mg2+ is necessary for this reaction. In the reaction, oxyluciferin is 
formed in an excited state and then quickly relaxes to its ground state releasing a photon. 
The complete reaction is extremely fast, with the first photons being produced 25 ms after 
mixing of the components. When a non-saturating concentration of ATP is present, light 
emission reaches a maximum at 300 ms28. The luciferase reaction is also very efficient, 
having a quantum efficiency of 0.88. Thus, 88 % of ATP molecules which react with 
luciferin lead to the production of a photon. This compares well with other common 
bioluminescence reactions. For example, the quantum efficiency of peroxidase-catalyzed 
reaction of luminol and hydrogen peroxide is twenty times lower than that of luciferase29. 
For these reasons, detection of ATP via bioluminescence is very sensitive. ATP 
concentrations in the low fmole region are routinely detected employing commercially 
available kits. These kits have been applied in numerous situations, including quantifying 
intracellular ATP concentrations30"31 and release of ATP from cultured cells32"34. However, 
without the concurrent use of an imaging scheme, ATP can only be detected on bulk samples 
and cannot be monitored in real-time. 
Fluorescence Microscopy 
Overview 
Imaging techniques provide the ability to monitor many samples simultaneously, but 
separately. When coupled to sensitive and selective detection schemes, these methods afford 
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the ability to monitor a particular anaiyte continuously. In the field of biosciences, 
fluorescence microscopy is an indispensable imaging technique. 
Instrumentation 
The fluorescence microscope consists of four main components: the light source, wavelength 
selection optics, microscope objective, and detector. Mercury lamps are the most common 
source in fluorescence microscopy as they emit strongly over the entire visible and UV 
regions of the spectrum. The proper excitation wavelength is isolated by inserting a 
bandpass filter into the light path of the lamp. This filter selects only the wavelength of light 
necessary for excitation of the fluorescence probe of interest. The excitation light is focused 
onto the sample through the microscope objective lens. Emitted fluorescence is collected by 
the same microscope objective. A dichroic mirror is commonly employed to separate the 
excitation and emission photons. The excitation light enters the microscope 45° incident on 
the dichroic. This light is reflected 90° and proceeds through the objective to the sample. 
Since it has longer a wavelength, fluorescence collected from the sample is transmitted 
through the dichroic mirror to the detector. Another bandpass filter is placed just in front of 
the detector to eliminate any excitation light or stray light which passed through the dichroic 
mirror35. Many of the recent advancements in fluorescence microscopy have involved its 
detectors. Thus, they are discussed in greater detail in the following two sections. 
Single Element Detectors 
Detection schemes applicable for fluorescence microscopy can be broadly classified as either 
single- or multi-element. The photomultiplier tube (PMT) is the most commonly employed 
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single element detector. It has the highest sensitivity of any detector used for fluorescence 
microscopy. Fluorescence photons collected by the microscope are focused onto the 
photocathode of the PMT. An incident photon causes ejection of an electron from the 
photocathode. This electron is accelerated to the first dynode of the PMT by an applied 
electric field. Upon striking this dynode, the electron induces expulsion of several new 
electrons because of its high kinetic energy from acceleration. This process continues for all 
of the dynodes until the photons reach the anode, where the current from the collected 
electrons is measured. The PMT is extremely sensitive due to the multiplication of signal by 
the dynodes and the low dark current associated with its operation36. However, the PMT is 
still a single-element detector and thus cannot offer significant spatial resolution unless 
coupled with a scanning microscope. For this reason, PMTs are most commonly utilized in 
confocal microscopy. 
Multi-Element Detectors 
Utilizing multi-element detectors affords excellent spatial information in fluorescence 
microscopy. Of the numerous multi-element detectors that exist today, the silicon intensified 
target (SIT) and charge coupled device (CCD) cameras find the most widespread application. 
For a SIT, photons are collected on a photocathode where they induce release of an electron, 
similar to that of the PMT. This electron is accelerated through an electric field where it 
impacts the silicon target of the SIT. Here electron-hole pairs are formed and stored until 
they are read out by a sweeping electron beam. SITs yield excellent sensitivity and dynamic 
range but suffer from two especially severe drawbacks. SITs are prone to target damage if 
exposed to excessive photons. Moreover, SITs suffer from incomplete readout leading to 
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residual signal being present in subsequent images37. For these reasons, SITs generally have 
been replaced by CCDs in fluorescence microscopy. CCDs are solid-state detectors first 
developed by Boyde and Smith at Bell Labs in 1969. However, they were mainly employed 
in astronomy until the pioneering work by Denton and colleagues in the early 1980s38"39. 
Photons incident on the CCD create electron-hole pairs upon striking the silicon collection 
areas. The electrons created are stored in minute voltage-defined areas or pixels of the 
silicon surface. The stored electrons are then shifted toward and to the output node where 
they are measured as current. While the CCD does not suffer from the same problems as 
does the SIT, significant drawbacks of CCDs still exist. For one, CCDs usually contain 
100,000 - 1,000,000 individual pixels which need to be individually quantified. Since 
photons incident on the camera must be blocked during this time, the data acquisition rate 
suffers. However, this problem was alleviated by the development of frame-transfer 
cameras. Frame transfer involves transferring an entire image to a separate (read-out) set of 
pixels. These pixels are quantified while new data are acquired on the original set of pixels. 
A further disadvantage of CCDs is that they do not have any signal multiplication as do 
PMTs and SITs and thus lack sensitivity for low level signals. To overcome this limitation, 
an intensifier plate was integrated into the CCD. Photons incident on this intensified CCD 
(iCCD) strike the photocathode of the image intensifier and induce expulsion of an electron. 
This electron is accelerated in the presence of an electric field through a channel towards the 
CCD collection pixels. The electron collides with the walls of the channel, ejecting several 
new electrons. This process occurs numerous times within the channel creating many 
electrons from a single photon. Finally, upon striking the fluorescence screen at the end of 
the image intensifier, an electron causes a photon to be emitted, which is then collected by 
10 
the CCD pixels. iCCDs allow for detection of extremely low light levels, approaching the 
detection limit of a PMT. However, with the use of an image intensifier comes a loss in 
spatial resolution, since coupling an image intensifier channel to a single CCD pixel has been 
unsuccessful to date. Instead there is usually slight cross-talk amongst a few pixels from a 
single intensifier channel37'40. A relatively new development in CCD detection is the use of 
an image intensifier during data read-out rather than collection. Roper Scientific utilized 
electron acceleration through a series of dynodes prior to quantitation at the output node41. 
Though still in its infancy, this amplification scheme has shown great potential in the field of 
CCDs. 
Cell Calcium 
One of the most common applications of fluorescence microscopy is monitoring intracellular 
calcium (Ca2+) concentrations. Ca2+ is an extremely important mediator of cell function. It is 
maintained at low concentrations in the cytoplasm of a cell. Ca2+ is instead stored inside the 
endoplasmic reticulum and mitochondria of the cell as well as in the extracellular matrix 
between cells. Upon stimulated release into the cytoplasm, Ca2+ activates numerous cellular 
pathways while inhibiting others. Essential bioprocesses such as exocytosis, initiation of 
embryonic development in a newly formed zygote, and muscle contraction are all Ca2+-
dependent8. Thus, monitoring cellular Ca2+ levels has been of acute interest to scientists. 
Ca2+ Indicator Dyes 
The development of synthetic Ca2+-sensitive dyes ushered in the widespread application of 
cellular imaging in live cells. Tsien and coworkers developed the first such indicator, Quin-
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242. This compound was followed by the development of superior indicators such as indo-1 
and fluo-343. These compounds, which are not fluorescent in their uncomplexed form, 
become highly fluorescent in the presence of Ca2+. Fura-2 is a Ca2+ indicator which has 
found widespread use recently because it allows for quantitation. By measuring the ratio of 
fluorescence at 340 and 380 nm, the ratio of uncomplexed to complexed fura-2 can be 
attained. This ratio is quantitative for Ca2+ over a large range of concentrations. One 
difficulty with all of these Ca2+ indicators is that they are negatively-charged and thus cannot 
pass through the phospholipid membrane of a cell. Hence, microinjection is the only 
plausible method for obtaining sufficient levels of the indicator in the cells. However, 
microinjection is time-consuming, difficult, and not amenable to all cell types44. This 
obstacle was overcome by the development of acetoxymethyl (AM) ester forms of the above 
dyes. Since the AM ester indicators are neutral compounds, they can pass through the 
plasma membrane into the cytoplasm of a cell45. There the AM ester is cleaved from the 
indicator by cellular phosphodiesterase enzymes. The resultant carboxyl form of the dye is 
again impermeable to the plasma membrane but this time is trapped inside the cell. The dye 
concentration builds up in the cell to levels much higher than that in the loading solution44. 
Detection of Ca2+/indicator fluorescence was first accomplished from a suspension of cells 
on a luminometer with a PMT detector. However, much of fluorescence microscopy now 
involves monitoring Ca2+ levels with a CCD. Through the proper choice of wavelength 
selecting optics, Ca2+ signaling can be obtained in real-time for numerous cells 
simultaneously. Thus, intercellular communication can be investigated by monitoring the 
21 * Ca response of cells to the stimulation of an adjacent cell. Alternatively, through use of a 
high magnification objective, Ca2+ release can be monitored spatially within a single cell. 
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Neurotransmitter Imaging 
Neurotransmission represents one of the most important processes in the body. Likewise, it 
is also one of the most complex. Neuroscientists have acute interest in monitoring real-time, 
spatially-resolved release of neurotransmitters. However, most neurotransmitters, including 
glutamate, acetylcholine, epinephrine, norepinephrine, serotonin, and the oligopeptide 
transmitters, lack fluorophores for detection with traditional fluorescence microscopy. 
Numerous alternative methods for detection of neurotransmitters have been recently reported 
in the literature. Many of these applications are discussed in chapter 3 of this dissertation. 
Several advances in fluorescence microscopy for the detection of neurotransmitters have also 
been achieved over the past ten years. In general, these techniques have involved detection 
of native fluorescence from neurotransmitters. Because neurotransmitters lack the efficient 
fluorophores of dyes, lasers are employed as light sources for native fluorescence detection in 
fluorescence microscopy. In 1995, Tan and colleagues monitored uptake of serotonin by 
astrocytes by native fluorescence microscopy. They discovered that various areas within a 
singular astrocyte uptake and release different quantities of serotonin46. In further studies, 
Lillard and Yeung investigated exocytosis from mast cells was stimulated with polymyxin. 
Serotonin was secreted in large initial bursts followed by a prolonged plateau level of 
release47. With the development of iCCD for detection of lower light samples, other 
neurotransmitter detection schemes have arisen for fluorescence microscopy. Tong and 
Yeung reported the visualization of catecholamine release from chromaffin cells with native 
fluorescence using the 275 nm line of an Ar+ ion laser. Great heterogeneity was observed 
amongst various cells and within individual cells48. Wang and coworkers developed a 
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method to detect glutamate in fluorescence microscopy. The enzyme glutamate 
dehydrogenase (GDH) was employed to catalyze the formation ofNADH in the presence of 
glutamate. NADH, which is highly fluorescent, was detected with an iCCD. The release of 
glutamate from cultured neurons was detected upon stimulation with K+'49"50. 
Bioluminescent Imaging of ATP 
Previously in our group, bioluminescent detection of ATP was coupled with real-time 
imaging on a microscope. Because detection of ATP was based on bioluminescence rather 
than fluorescence, neither a light source nor wavelength selection optics were necessary for 
these experiments. With no light source, the majority of the noise involved with standard 
fluorescence microscopy is removed, including both scattering of the source light and 
autofluorescence from the biological sample. Furthermore, the removal of the wavelength 
selection optics eliminates loss of signal light due to reflections at the filter surfaces. By 
using an iCCD cooled to -30°C to eliminate dark noise, detection of ATP was performed in a 
~ zero noise environment. Thus, detection of standards down to 10 nM ATP was 
accomplished with their set up. This method was applied to the detection of ATP release 
from physically stimulated astrocytes. Furthermore, intracellular Ca2+ levels were monitored 
simultaneously with ATP imaging via laser-induced fluorescence on every other frame of 
data. From these analyses, an IPg-sensitive, Ca2+-insensitive ATP release mechanism was 
elucidated. Furthermore, extracellularly released ATP was unequivocally shown to signal 
intracellular Ca2+ signaling in nearby astrocytes51. Since this first report of ATP detection 
via fluorescence microscopy, several other investigators have employed this scheme for 
analysis of ATP release in various environments52"54. 
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Chemical Imaging of ATP 
The properties that make real-time imaging of ATP release appealing on the single cell level 
are also attractive in chemical imaging. Biocompatible mesoporous nanospheres are being 
designed to reversibly entrap drug compounds. Characterization of the encapsulation and 
release properties of these particles is imperative to their development. ATP is a potentially 
suitable probe molecule for these investigations. Nanospheres have dimensions on order of a 
single micron or less, compared to 10 jam for an average eukaryotic cell. Thus, an imaging 
technique would allow the simultaneous monitoring of release from numerous nanospheres 
individually. Furthermore, the high speed and sensitivity of ATP bioluminescence imaging 
with an iCCD allow for monitoring release on the second - millisecond timescale. ATP is 
also an excellent probe molecule because it is a biological compound and is employed in the 
treatment and diagnosis of numerous ailments55. 
Our Goal 
The importance of ATP in bioanalytical sciences has been thoroughly underscored 
throughout this introduction. The ATP imaging technique developed in our lab by Wang and 
coworkers possesses several properties make it potentially useful in innumerable systems. 
Our goal was to investigate just a few of the possible applications of real-time ATP imaging 
for in vitro biopathway investigation, in vivo cellular signaling, and fundamental chemical 
analysis. 
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ABSTRACT 
Extracellular ATP is an important mediator of communication among endothelial 
cells. ATP binds to purinergic receptors that regulate Ca2+ signaling, nitric oxide production, 
and cAMP levels. While the effects of extracellular ATP stimulation on endothelial cells are 
well documented, the source and mechanism by which ATP is released have not been 
examined thoroughly. In this study, we investigated G protein-stimulated release of ATP 
from human umbilical vein endothelial cells (HUVECs) using the G protein stimulant 
compound 48/80. Application of compound 48/80 resulted in dose-dependent ATP evolution 
from cultured HUVECs. This release of ATP was not cytotoxic as demonstrated by a lactate 
dehydrogenase (LDH) toxicity assay and the ability of the cells to load and retain the 
viability dye calcein following stimulation. Mastoparan also stimulated release of ATP, 
further suggesting the process was G-protein initiated. This G protein was insensitive to 
pertussis toxin (PTX) and appeared to be of the Gq-subtype. The ATP efflux was completely 
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abolished in the presence of EGTA and thapsigargin, signifying a strict Ca2+ dependence. 
Furthermore, compound 48/80-induced ATP release was significantly decreased in cells 
pretreated with the phospholipase C (PLC) inhibitor U73122. Thus, the release pathway 
appears to proceed through an increase in intracellular Ca2+ via PLC activation. 
Additionally, the G protein-initiated release of ATP was attenuated by pretreatment of the 
cells with either phorbol ester or indolactam V, activators of protein kinase C. Finally, this 
release was not affected by treating HUVECs with nitric oxide synthase inhibitors or 
glybenclamide. We compared these results to the existing theories of cellular ATP release, 
and they correlated best with release via a non-specific plasma membrane channel. 
INTRODUCTION 
The role of ATP as an intercellular messenger has attracted widespread interest over 
the past ten years. The binding of ATP to purinergic receptors on the surface of cells initiates 
receptor-mediated responses. These purinergic receptors are classified into two categories: 
ion channel-coupled P2X type and G protein-coupled P2Y type. P2 receptors are further 
classified by their pharmacological and genetic properties (1,2). Their activation initiates 
several different second messenger pathways in many types of cells, including neurons, 
smooth muscle cells, mast cells, and epithelial cells (3). The most thoroughly investigated of 
these pathways is the elevation of intracellular Ca2+ levels via activation of PLC and 
subsequent production of inositol (1,4,5) triphosphate (IP3). IP3 binds to receptors on the 
endoplasmic reticulum, releasing stored Ca2+. Increasing intracellular Ca2+ initiates/regulates 
numerous cellular responses, such as insulin secretion in p-cells (4), synaptic transmission in 
neurons (5, 6), mast cell degranulation (7), and platelet aggregation at injury sites (8). 
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ATP signaling in endothelial cells appears to be important for proper endothelium 
function. Activation of endothelial cells by ATP in vitro has been shown to increase 
cytosolic Ca2+ levels and consequently to cause production of nitric oxide (NO) (9). NO 
regulates endothelium vascular tone, inhibits platelet aggregation, and reduces vascular 
smooth muscle proliferation in the cardiovascular system (10). Ca2+ signaling also activates 
secretion of von Willebrand factor from the Wiebel-Palade bodies, the main exocytotic 
vesicle in endothelial cells (11). A number of other important effects occur in endothelial 
cells upon increase of intracellular Ca2+, including release of prostacyclin and endothelin-1 
and an enhancement in microvascular permeability (see reference 12 for a review). 
While much is known about the stimulatory effects of ATP on endothelial cells, the 
source of this ATP is unclear. One possibility is secretion of ATP stored in exocytotic 
vesicles. A number of researchers have reported ATP being copackaged with either 
norepinephrine or acetylcholine in neuronal synaptic vesicles where it acts as a fast 
excitatory neurotransmitter (13 -15). Vesicular release of ATP has also been observed in 
chromaffin cells and epithelial cells (15), but has yet to be reported in endothelial cells. The 
cytoplasm is the other obvious source for release. Under extreme circumstances, ATP may 
be liberated from a cell's cytoplasm following lysis. However, recent evidence suggests that 
release of ATP from the cytosolic pool may also occur in a regulated, non-cytotoxic manner. 
ATP is reported to be released from many cell types via ATP binding cassette proteins, such 
as the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel (16). 
The concept of this ion channel being able to pass a large highly charged molecule like ATP 
is at this time highly controversial, and numerous researchers have reported conflicting 
results on the matter (15, 17). 
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Mechanical stimulation also results in release of ATP in numerous cell lines (18 -
20). Stout et al. have recently postulated that ATP is released through connexin proteins in 
mechanically stimulated astrocytes (21). Connexins commonly form gap junctions between 
cells, but can also form channels to the extracellular matrix termed hemichannels (22). The 
presence of hemichannels and their ability to release small dye molecules has been known for 
some time. Cotrina and coworkers previously discovered that C6 glioma cells with increased 
connexin43 expression release larger amounts of ATP than do control cells (19). A recent 
report by Arcuino et al. lends support to this proposed release mechanism (23). They note 
that release of ATP from the cytoplasmic pool represents a viable method for cellular 
communication in nonexcitable cells. Furthermore, numerous surrounding cells can be 
influenced by the release of ATP in this manner, because the concentration of ATP in the 
cytoplasm is ~2 mM (23). 
In this study, we performed experiments on human umbilical vein endothelial cells, a 
popular model for the investigation of endothelium function. The G protein agonist 
compound 48/80 was employed to stimulate release of ATP from HUVECs. 
Bioluminescence produced by the reaction of luciferin and ATP in the presence of firefly 
luciferase was monitored in real-time on a microscope equipped with an intensified CCD. 
Ca2+ imaging was conducted on the same set up and served in both experimental and control 
capacities. G protein initiated-ATP efflux from HUVEC cultures was dose-dependent and 
occurred concurrently with an increase in intracellular Ca2+ levels. Several of the key 
enzymes and second messengers involved in this ATP release mechanism were identified, 
and release in HUVECs was compared to other proposed pathways. 
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EXPERIMENTAL SECTION 
Chemicals- Compound 48/80, thapsigargin, and EGTA were purchased from Sigma 
(St. Louis, MO). Firefly luciferase (from Photinus pyralis) and D-luciferin were obtained 
from both Sigma and R&D Systems (Minneapolis, MN). BAPTA AM, fluo-3 AM, calcein 
AM, and Pluronic F-127 were from Molecular Probes (Eugene, OR). U73122 (l-[6-([(17/7)-
3-methoxyestra-l,3,5(10)-trien-17»yl]amino)hexyl]-lH-pyrrole-2,5-dione) and U73343 (1-
[6-([(17P)-3-methoxyestra-l,3,5(10)-trien-17-yl]amino)hexyl]-2,5-pyrrolidinedione) were 
purchased from both Calbiochem (La Jolla, Ca.) and Sigma. All other drugs were from 
Calbiochem. U73122, U73343, phorbol-12-mystirate-13-acetate (PMA), Go6893, 
bisindolylmaleimide (BIM), indolactam V, thapsigargin, BAPTA AM, fluo-3 AM, and 
calcein AM were dissolved in dimethylsulfoxide (DMSO, Sigma) as stock solutions. 
BAPTA AM, fluo-3 AM, and calcein AM were diluted 1000-fold in buffer containing 0.1 % 
Pluronic F-127 (20% in DMSO) to aid in solubilization of the dye. All other drugs were 
diluted to the pretreatment concentration in imaging buffer. The concentration of DMSO in 
pretreatment solutions never exceeded 0.3%. 
Cell Cultures- Human umbilical vein endothelial cells (HUVECs) were purchased 
from American Type Culture Collection (Manassas, VA). Cells were grown in Medium 199 
(Life Technologies, Rockville, MD) supplemented with 10% fetal bovine serum, 100 U/ml 
penicillin, and 100 fj.g/ml streptomycin. Cells were plated on 22 x 22 mm square coverslips 
coated with poly-L-lysine (Sigma) substrate. Teflon O-rings (Small Parts, Inc., Logansport, 
IN) were attached to coverslips with Sylgard 184 (Dow Corning, Midland, MI) prior to 
coating with poly-L-lysine and acted as solution chambers. Cells were grown at 37°C in an 
atmosphere of 95% air-5% CO%. Prior to stimulation, cells were rinsed with buffer (135 mM 
NaCl, 5 mM KC1, 2 mM MgCl2, 2 mM CaCli, 10 mM HEPES (4-(2-hydroxyethyl)-1 -
piperazineethanesulfonic acid) and 10 mM glucose (pH - 7.3)). In experiments performed 
with buffers containing different concentrations of Ca2+, the ionic strength of the solution 
was maintained by varying the sodium concentration accordingly. Experiments were 
conducted only on confluent cultures. Experiments were performed on cultures between 15 
and 25 total passages. 
ATP Imaging- ATP imaging was performed on the stage of an inverted microscope 
(Axiovert 100 TV, Zeiss, Germany). Bioluminescence signal was collected with a Zeiss 
Apochromat 20X microscope objective (NA = 0.75) and detected with an intensified charge-
coupled device (iCCD; EEV 576 x 384 pixels CCD chip, Roper Scientific, Trenton, NJ) 
attached to the camera mount of the microscope. Cells were incubated in 100 pi buffer 
containing 100 pg/ml firefly luciferase and 205 pM D-luciferin. Images were collected at a 
frequency of 1.33 Hz with 500 ms exposure times. All experiments were performed at room 
temperature. Stimulant was applied to the cells via a 10 pi Hamilton syringe in the first ten 
frames of the collected images. The camera offset was removed by subtracting an image file 
collected with the camera shutter closed. 
Ca2+ Imaging- The same experimental set up was utilized for Ca2+ imaging as was 
used for ATP imaging. HUVECs were loaded for 50 min at room temperature with 8.85 pM 
fluo-3 AM in buffer with reduced Ca2+ (200 pM). The cells were then incubated, also at 
room temperature, for an additional 30 min in buffer to allow for complete de-esterification 
of the fluo-3. Excitation was accomplished using a Zeiss Atto Arc HBO 100 W mercury 
lamp with a 475 +/- 20 nm bandpass filter. Fluorescence emission was isolated via a 505 nm 
dichroic mirror and a 530 +/- 18 nm bandpass filter prior to detection with the iCCD. No 
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autbfluorescence was detected at the wavelengths utilized. The exposure time of the iCCD 
and the power of the mercury lamp were varied based on the efficiency of the fluo-3 loading 
of each individual coverslip. 
Cytotoxicity Assay- LDH assays (Sigma) were performed at room temperature on a 
UV-VIS absorbance spectrometer (HP 8452A Diode Array Spectrophotometer, Hewlett 
Packard, Palo Alto, CA). Coverslips were rinsed with buffer three times at 15-minute 
intervals. The final rinse from each coverslip was collected as a background sample. 
Compound 48/80, A23187, or buffer was added to each coverslip and then sampled after 10 
minutes. The LDH content was determined by adding the assay solution (50 pi) to each 
sample (100 |il) and allowing the assay reaction to proceed for 25 min. The assay reaction 
involves the reduction of NAD+ to NADH by LDH. NADH then reduces a colorless 
tetrazolium dye to its colored form. The reaction was halted with 1 M HC1 (15 pi), and the 
peak absorbance of each sample was evaluated from 480-500 nm to quantitate LDH. For 
control coverslips (buffer as stimulant), an additional step was performed. After the 
background and experimental samples were obtained, 20 pM digitonin was added to the 
coverslip to achieve total lysis of the cells. Complete cell lysis was estimated by optically 
observing the morphological change of digitonin-stimulated cells. The digitonin-treated 
sample was diluted with buffer until its absorbance neared that of the compound 48/80 and 
A23187-treated samples. This sample was assayed identically to the others and served as the 
maximum releasable LDH. 
Calcein Loading Efficiency- Calcein loading efficiency was carried out on the same 
fluorescence microscope setup as was used for Ca2+ imaging. Dishes containing HUVECs 
were stimulated with compound 48/80 or control (buffer). After 15 min, the cells were 
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rinsed and incubated in buffer containing 1 p.M calcein AM for 45 min at room temperature 
and in buffer for 20 min at room temperature to allow for loading and complete de-
esterification of calcein, respectively. Cell viability was expressed as the percent of cells 
able to load calcein. 
Calcein Leakage- Again the same instrumental set-up was employed for calcein leak 
experiments as for Ca2+ imaging. Dishes of HUVECs were loaded with 1 p,M calcein AM in 
buffer for 45 min at room temperature. After incubation in buffer for 20 min to allow de-
esterification of the dye, compound 48/80 or buffer was added to the dishes. The number of 
cells exhibiting fluorescence was monitored prior to and following stimulation. The percent 
of calcein-loaded cells maintaining fluorescence was reported for both compound 48/80 and 
buffer-stimulated dishes. 
Data Presentation/Analysis- Bioluminescence and fluorescence signal were obtained 
and processed with Winview32 software (Roper Scientific). The mean bioluminescence 
signal was calculated for each frame of data. The net ATP signal was calculated by 
subtracting the pre-stimulation average signal from the maximum ATP signal. Except in the 
dose response curve, ATP data are reported as the percent counts of the experimental versus 
the control (compound 48/80 stimulation of untreated dishes, unless otherwise noted). For 
temporal responses, the initiation and maximal times represent the 10% and 90% maximal 
signals. Calcium fluorescence images were analyzed by subtracting a pre-stimulation image 
from all post-stimulation images. A cell was deemed as having signal only if its fluorescence 
after stimulation was ten times the background standard deviation. Identical processing was 
performed for calcein images except that the post-stimulation image was subtracted from a 
pre-stimulation image for calcein leak experiments. Standard errors were determined for 
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each condition based on the number of samples analyzed. A P value of <0.05 was 
considered significant as calculated by the Student's t-test for paired experiments. 
RESULTS 
Addition of the G protein stimulant compound 48/80 to confluent coverslips of 
HUVECs caused release of cellular ATP, as depicted in Figure 1 (A and B). ATP release was 
initiated 41.1 +/- 1.8 s (N = 30) after addition of 15 p.g/ml compound 48/80. The ATP signal 
reached a maximum at 126.2 +/- 5.8 s and slowly decreased back to basal levels (10 - 15 
min). For the injection displayed in Figure 1 (A and B), basal release of ATP was below our 
detection limits (<5 nM) while the maximal release was at approximately 600 nM ATP. 
Since a perfusion system was not utilized in these experiments, the slow decrease to basal 
levels could be a result of the continued presence of compound 48/80 and/or from ATP-
induced ATP release from HUVECs. The dose-dependence of compound 48/80-stimulated 
release of ATP is shown in Figure 1C. ATP efflux was not detected at compound 48/80 
concentrations lower than 5 pg/ml and plateaued at ~60 |-ig/ml compound 48/80 at around 4 
pM ATP. 
The toxicity of compound 48/80 to the HUVECs was also investigated. For this 
purpose, an LDH assay was employed. LDH is a large cytoplasmic protein whose release is 
a marker of the loss of cell membrane integrity. HUVEC plates were sampled prior to and 
following activation with compound 48/80, buffer, or the Ca2+ ionophore A23187. A23187 
was utilized as a control stimulant since it activates HUVECs by increasing the cell's 
intracellular Ca2+ concentration, as does compound 48/80 (see below). Buffer-stimulated 
control plates were sampled further after lysing the cells with digitonin. The results of the 
LDH assay are depicted in Table 1 A. Compound 48/80-induced release of LDH was almost 
two orders of magnitude lower than that obtained from cell lysis. Furthermore, the LDH 
levels obtained for compound 48/80 stimulation were not significantly different than those 
obtained for stimulation with A23187 or buffer. The possible cytotoxic effects of compound 
48/80 were further examined with the cell viability dye calcein AM. HUVECs were able to 
load and maintain calcein dye both prior to and after exposure of HUVECs to 15 pg/ml 
compound 48/80 (Table IB). A second test for cytotoxicity using calcein is the ability of a 
cell to maintain the loaded dye upon stimulation. When 15 ng/ml compound 48/80 was 
added to calcein-loaded HUVECs, 48.9 +/- 9.8 % of the cells failed to maintain calcein 
fluorescence (Table 1C). Taken together, the three assays suggest that upon stimulation with 
compound 48/80 the HUVEC membrane is permeable to calcein (622 Da) but not LDH (134 
kDa). This permeability to calcein is not permanent and ceases upon removal of compound 
48/80. 
Next we attempted to confirm that a G protein was indeed the initiation site for 
compound 48/80-induced ATP release. Direct stimulation of HUVECs with another G 
protein stimulant, mastoparan, also produced significant release of ATP. As shown in Figure 
2 (A and B), mastoparan produced 67.2 +/-10.8 % (N = 3) as much ATP release as did 
compound 48/80. The onset of ATP release (38.4 +/- 5.8 s and 104.1 +/- 8.1 s, N = 4) was 
similar to that of compound 48/80-induced release. PTX, an inhibitor of G, and G0 but not 
Gq proteins, was utilized to further investigate the involvement of G proteins in initiating 
release of ATP. As shown in Figure 2 (A and B), overnight incubation of HUVECs with 
PTX did not alter the magnitude of compound 48/80-evoked ATP efflux (95.2 +/-13.9 % (N 
= 22) of buffer-pretreated HUVECs). Furthermore, PTX treatment did not significantly 
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affect the temporal onset (43.8 +/- 3.0 s, N = 22) of G protein-initiated release of ATP. Thus 
a Gq protein is the probable initiation site for compound 48/80-induced ATP efflux. 
Addition of compound 48/80 to HUVECs also stimulated increases in intracellular 
Ca2+ as depicted in Figure 3 A. 83.7 +/- 3.3 % of cells responded with increased Ca2+ levels 
upon addition of 15 pg/ml compound 48/80 (N = 15). The temporal onset and maxima of 
Ca2+ increase were 37.3 +/-1.5 s and 51.2 +/-1.9 s (N = 42). The temporal onset of both 
Ca2+ and ATP release were quite similar. Thus, the ATP and Ca2+ responses were further 
investigated to determine whether: 1) the Ca2+ increase was the result of ATP release, 2) the 
Ca2+ increase was necessary for the release of ATP, or 3) the two were simply two parallel 
results of the same stimulation. Thapsigargin (Tg), an inhibitor of Ca2+ ATPases, was 
employed to deplete intracellular Ca2+ stored within the ER, and 100 pM EGTA in Ca2+-free 
buffer was used to remove the extracellular Ca2+ source. As depicted in Figure 3 (B and C), 
compound 48/80-stimulated cells pretreated for 20 min with both Tg and Ca2+-free buffer did 
not release significant amounts of ATP (5.9 +/- 2.7 % of control, N = 6). Also, the temporal 
onset of ATP release under these conditions was significantly delayed (initiation at 84.6 +/-
10.7 s) for HUVECs that did exhibit ATP release. Ca2+ imaging confirmed that under Ca2+-
free conditions compound 48/80 did not cause significant Ca2+ increases (3.2 +/- 2.3 % of 
cells responded, N = 9) in HUVECs as shown in Figure 3 (D and E). These data suggest that 
G protein-initiated release of ATP from HUVECs is strictly Ca2+ dependent. 
Based on these results, the possibility that increasing intracellular Ca2+ levels alone 
was sufficient for initiating ATP efflux from HUVECs was investigated. Exposure of cells 
to the Ca2+ ionophore A23187 (10 (iM) in buffer containing 4 mM CaCh (double that of the 
control imaging buffer) failed to stimulate significant release of ATP without the addition of 
compound 48/80. As shown in Figure 3 (B and C), A23187 caused 5.2 +/- 0.3 % (N = 3) of 
the ATP release as did 15 pg/ml compound 48/80, while buffer alone produced 4.5 +/-1.7 % 
(N = 3). Ca2+ imaging demonstrated that intracellular Ca2+ was increased in 89.6 +/- 0.6 % 
(N = 3) of cells, as depicted in Figure 3 (D and E). Likewise, direct stimulation of HUVECs 
with 5 pM thapsigargin increased intracellular Ca2+ levels in 92.1 +/- 4.2 % (N = 3) of cells 
(Figure 3 (D and E)), but was unable to induce release of ATP (4.8 +/- 0.7 % (N = 3) versus 
release caused by compound 48/80), as illustrated in Figure 3 (B and C). These experiments 
provide evidence that ATP release from HUVECs was dependent not only on increased 
intracellular Ca2+ levels, but also on at least one other as of yet unidentified factor. 
Next, experiments were conducted to determine whether the Ca2+-based control of G 
protein-initiated ATP release in HUVECs was exerted through the well-established 
phospholipase C/IP3 pathway. Prior to stimulation, cells were incubated for 30 min in 
imaging buffer containing either U73122 or U73343, an inhibitor of phospholipase C and its 
inactive analog, respectively. When stimulated with compound 48/80 under extracellular 
Ca2+-free conditions, ATP release from HUVECs was significantly inhibited in cells 
pretreated with U73122 (12.7 +/- 3.4 % of cells pretreated with U73343, N = 6) as shown in 
Figure 4 (A and B). When extracellular Ca2+ was restored and EGTA was removed, U73122 
still attenuated stimulated ATP release but to a lesser degree (20.9 +/- 8.9 % of U73343 
treated cells, N = 4). Ca2+ imaging confirmed that intracellular Ca2+ signaling was reduced in 
compound 48/80-stimulated HUVECs pretreated with U73122 with and without extracellular 
Ca2+ present. As shown in Figure 4 (C and D), 64.6 +/- 10.6 % (N = 4) of cells responded 
with increased Ca2+ when cells were pretreated with U73122 compared to 81.4 +/- 4.1 % (N 
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= 8) of cells pretreated with U73343. Additionally, when Ca2+ was removed, only 25.0 +/-
10.6 % (N = 12) of U73122 treated cells responded with increased Ca2+ versus 67.7 +/-16.0 
% (N = 4) for U73343. The temporal initiation of ATP release was extended slightly in cells 
pretreated with U73122 (49.5 +/- 9.1 s and 49.4 +/-12.3 s under Ca2+-free conditions and 
Ca2+-present conditions, respectively), for those cells in which release was detected (3 of 7 
for U73122 under Ca2+-free conditions and 5 of 7 for U73122 under Ca2+-present 
conditions). Moreover, U73343 did not appear to affect ATP or Ca2+ signaling. The 
temporal response of compound 48/80-stimulated cells pretreated with U73343 with and 
without Ca2+ present were not significantly different than those obtained for buffer and 
EGTA treatment, respectively (data not shown). Together with the earlier experiments, these 
results suggest that G protein-activated release of ATP proceeds via activation of 
phospholipase C and subsequent increases in intracellular Ca2+. 
The protein kinase C dependence of G protein-initiated ATP release was also 
examined. Phospholipase C, which produces IP3, additionally generates diacylglycerol 
(DAG). When activated by DAG, protein kinase C modulates Ca2+ signaling in HUVECs 
(24) and thus could be involved in ATP release. As illustrated in Figure 5 (A and B), 
pretreatment with neither bisindolylmaleimide (BIM) nor Go6893, both inhibitors of PKC, 
altered the magnitude of compound 48/80-stimulated release of ATP (102.8 % +/- 4.9, N = 7 
and 95.1 % +/- 8.9, N = 6 of controls, respectively). Likewise pretreatment with BIM or 
Go6893 did not significantly affect the temporal onset of ATP release. Hence, activation of 
PKC did not appear to be necessary for compound 48/80-induced release of ATP. Next, the 
effect of PKC activation on ATP efflux was studied using the PKC activators phorbol-12-
mystirate-13-acetate (PMA) and indolactam V. Figure 5 (C and D) shows the ATP release 
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for compound 48/80-stimulated HUVECs pretreated with PMA and indolactam V. As 
depicted, treatment with the PKC activators reduced the magnitude of stimulated ATP 
release from HUVECs (14.2 +/- 3.4, N = 7 and 56.8 +/- 9.9 %, N = 7 of control, 
respectively). The temporal initiation of ATP release was delayed in compound 48/80-
stimulated HUVECs pretreated with PKC activators (59.9 +/- 8.6 s, N = 10 and 49.7 +/- 3.1 
s, N = 7 for PMA and indolactam V, respectively) versus buffer only (41.2 +/-1.8 s). 
We then examined whether the production of nitric oxide was involved in G protein-
initiated release of ATP in HUVECs. As mentioned earlier, increases in intracellular Ca2+ 
activate nitric oxide synthase (NOS). The results of experiments conducted with the NOS 
inhibitors L-NAME and L-NMMA are depicted in Figure 6 (A and B). The magnitude of 
compound 48/80-stimulated release of ATP was not significantly altered in either L-NAME 
or L-NMMA pretreated cells (96.0 +/- 6.7 %, N = 8 and 95.7 +/- 8.3 %, N = 7 of untreated 
cells, respectively). Additionally, the temporal onset of ATP release for inhibitor-treated 
cells was not significantly different than that of control cells. Thus it appears that nitric 
oxide production is not necessary for G protein-initiated release of ATP. 
Finally, we wanted to determine if compound 48/80-induced release of ATP in 
HUVECs occurred via a CFTR-transmembrane ion channel. Glybenclamide blocks CFTR 
channels and is commonly employed to identify CFTR-coupled release. In HUVECs treated 
with 100 jiM glybenclamide, compound 48/80-induced release of ATP was not significantly 
modified. As shown in Figure 7 (A and B), the magnitude of release was 96.3 +/- 10.3 % (N 
= 6) of control dishes and its onset occurred at 39.3 +/- 2.9 s. These results generally suggest 
that ATP release in this G protein-initiated pathway was not occurring through a CFTR 
channel. 
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DISCUSSION 
This study investigated the pathway through which human umbilical vein endothelial 
cells release ATP when stimulated with the mast cell degranulator compound 48/80. 
Compound 48/80 probably initiates the release pathway by activating a Gq protein. Gq 
proteins have been previously identified in HUVECs (25) and link G protein-coupled 
receptors to the activation of phospholipase C and subsequently to increases in intracellular 
Ca2+ levels (26). Also, Gq proteins, in HUVECs and in general, are not pertussis toxin 
sensitive (27). The next step in the release pathway appeared to be the activation of PLC by 
the Gq protein. PLC produced IP3 which caused release of Ca2+ from the ER, Ca2+ influx 
from the extracellular matrix, or both. 
Upregulation of PKC significantly attenuated ATP release. PKC activation, by 
treatment of the cells with PKC activators for -20-30 min, has been reported to inhibit PLC 
in many cell types, including endothelial cells (28 - 29). The rate and magnitude of release 
under conditions of PKC activation in our experiments were similar to those in U73122-
treated HUVECs. This suggested that protein kinase C possibly downregulated 
phospholipase C in our system. This mechanism could possibly act in feedback inhibition of 
ATP release. For instance, extended activation of the compound 48/80-stimulated G protein 
would result in the continued activation of PLC. PLC produces both IP3 and DAG, an 
activator of PKC. DAG would then stimulate PKC activity that would in turn result in the 
termination, or at least reduction, of ATP efflux. 
A number of recent studies have been published which are especially interesting in 
light of the results obtained in this paper. Stout and coworkers reported ATP release through 
connexin hemichannels in mechanically stimulated astrocytes (21). They noted that cells 
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loaded with calcein blue dye (MW = 400 Da) released the dye upon mechanical stimulation. 
However, neither Oregon Green (MW — 1100 Da) nor LDH (MW =134 kDa) was released 
under these same conditions. Moreover, the connexin channel inhibitor flufenamic acid 
attenuated the release of both calcein blue and ATP. Arcuino and colleagues undertook a 
similar study (23). They noted that ATP was released in astrocytes upon lowering 
extracellular Ca2+ levels. Fluorescence imaging revealed propidium (MW = 563 Da) and 
dicarboxy-dichlorofluorescein (MW = 445 Da) uptake also occurred upon stimulation. 
However, fluorescein-dextran conjugates (MW = 1.5 - 2,000 kDa) were unable to enter the 
astrocytes under identical conditions. Furthermore, connexin-deficient C6 glioma did not 
release ATP when stimulated. Like Stout and coworkers, Arcuino and colleagues 
hypothesized that connexin hemichannels may be the channel through which ATP efflux 
occurs. Finally, they also reported release of ATP from HUVECs and epithelial cells 
stimulated identically to the astrocytes. To date, the mechanism of nonspecific ATP release 
in astrocytes has not been identified. However, ATP release in both of these reports would 
correlate well with the pathway investigated here. We noted that HUVECs stimulated with 
compound 48/80 were still able to load and maintain calcein after compound 48/80 washout. 
However, we also observed that calcein preloaded into HUVECs was released upon 
stimulation with compound 48/80 while LDH was not. Moreover, compound 48/80 was also 
able to stimulate release of ATP from astrocytes. Like in HUVECs, this release of ATP was 
found to be Ca2+-dependent (30). If the release mechanisms in HUVECs and astrocytes 
indeed occur through similar or identical pathways, these papers together could provide a 
framework for what perhaps could be a more general pathway. Certainly, a more detailed 
inquiry will be necessary to determine if this is indeed true. 
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We could not rule out exocytosis as the source of ATP release in our experiments. As 
is typically the case in exocytosis, we observed a strict dependence on Ca2+ in our system. If 
calcein were confined to the exocytotic vesicles and released upon stimulation, the leakage 
could be explained. However, calcein fluorescence was very uniform across the cell 
suggesting this was not the case. Furthermore, the magnitude of ATP release (estimated to 
be in the high nM - low pM levels) seemed more indicative of release from the cytoplasm 
where ATP is plentiful (-2 mM) (23). We found no data to suggest the release of ATP 
occurred through a CFTR or other ATP binding cassette proteins. ATP release stimulated by 
compound 48/80 was not inhibited by glybenclamide. This is in contrast to the majority of 
proposed CFTR-permeable ATP release mechanisms (17). 
Release of ATP initiated by G protein activation in endothelial cells could potentially 
be an important pathway in the human body. As discussed earlier, released ATP causes the 
activation of several pathways in numerous cell types. Endothelial cells interact with many 
different cell types in the human body. These include smooth muscle cells around the blood 
vessels, glial cells in the brain, platelets and neutrophils in the blood, and other endothelial 
cells (31). Endothelial cells might influence the vasodilation/vasoconstriction of blood 
vessels by releasing ATP onto neighboring smooth muscle cells and onto other endothelial 
cells. ATP has been shown to induce the synthesis of NO, a major modulator of vascular 
smooth muscle tone, in endothelial cells (9). Therefore, release of ATP from endothelial 
cells might alter smooth muscle function both directly via activation of Ca2+-linked 
purinergic receptors on the smooth muscle cells and indirectly by stimulating production of 
NO (10). 
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Glial cell/endothelial cell interactions are responsible for communication across the 
blood brain barrier (31). Activation of endothelial cells by either the glial cells or 
compounds carried in the blood could induce ATP efflux. ATP would then act on 
endothelial cell purinergic receptors to regulate the microvascular permeability via regulation 
of intracellular Ca2+ signaling and cAMP levels (32). In addition, released ATP might 
activate Ca2+ signaling in glial cells, which has been implicated in the modulation of 
neuronal synaptic transmission (5, 6). ATP release from endothelial cells also appears to be 
exceedingly important in inflammation and wound healing. As mentioned earlier, ATP-
induced Ca2+ signaling in endothelial cells initiates production of NO. NO prevents adhesion 
of platelets and neutrophils to healthy endothelial cells (33). ATP released by endothelial 
cells also activates Ca2+ signaling in platelets and neutrophils. Activation of these cells 
induces their aggregation at wound sites, since damaged endothelial cells are unable to 
synthesize NO (33). 
In summary, the activation of G proteins in human umbilical vein endothelial cells by 
compound 48/80 was investigated. It was discovered that ATP is released upon stimulation 
of the cells. This release, which was seemingly initiated via a Gq protein, was modulated by 
PLC and subsequent Ca2+ signaling. The release did not appear to occur through a CFTR ion 
channel, but seems to correlate well with nonspecific, cytoplasmic release mechanisms 
recently postulated. 
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Table 1. Cytotoxicity of compound 48/80-induced ATP release on HUVECs. 
A) 
Stimulant LDH Release 
Buffer 
5 (J.M A23187 
25 (ig/ml Compound 48/80 
40 mM Digitonin 
0.62+/-0.11 
0.97+/-0.51 
1.15+/-0.13 
100+/-6.16 
B) 
Stimulant # of Cells Loading Calcein 
Buffer 
16.8 |-ig/ml Compound 48/80 
129.2+/-5.1 
136.0 +/- 5.2 
C) 
Stimulant % of Cells Leaking Calcein 
Buffer 
15 jj.g/ml Compound 48/80 
1.7+/-1.7% 
48.9 +/- 9.8 % 
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FIGURE CAPTIONS 
Figure 1. Compound 48/80-induced release of ATP in HUVECs. ATP signal was 
monitored from cultured HUVECs stimulated with 15 |ig/ml compound 
48/80. A, single frames of data are shown at various times after stimulation. 
B, concentration of ATP efflux following stimulation is plotted versus time 
after stimulation. C, the dose dependence of ATP release is depicted in a plot 
of the maximum ATP release versus compound 48/80 concentration. The 
overall curve is the combined data from five separate dose response curves 
obtained from HUVECs in different passages. All data points represent the 
combined data from at least five independent compound 48/80 injections, 
except for [compound 48/80] = 0 and 5 |xg/ml, for which only three injections 
were performed. 
Figure 2. G protein dependence of compound 48/80-induced release of ATP from 
HUVECs. HUVECs were stimulated with 10 pM mastoparan. HUVECs 
pretreated overnight with 250 ng/ml PTX or buffer were stimulated with 
15 fig/ml compound 48/80. Representative time courses of ATP release (A) 
along with plots of overall ATP release (B) are depicted. 
Figure 3. Compound 48/80 induces increases in intracellular Ca2+ and Ca2+-dependent 
release of ATP from HUVECs. Intracellular stores of Ca2+ were depleted by 
incubation of HUVECs with 250 nM thapsigargin for 20 minutes, and 
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extracellular Ca2+ was removed by bathing cells in buffer with Ca2+ removed 
and 100 p.M EGTA added to remove any residual Ca2+ ions (Tg/EGTA). 
Compound 48/80 induced intracellular Ca2+ increases in HUVECs loaded 
with fluo-3. Single frames of Ca2+ imaging data are depicted at various times 
after stimulation with 15 (J.g/ml compound 48/80 (A). Representative time 
courses of ATP release (B) and Ca2+ signaling (D) are depicted along with 
plots of overall ATP release (C) and Ca2+ signaling (E) for HUVECs 
stimulated with 15 (ig/ml compound 48/80 (Tg/EGTA and 48/80), 10 JLIM 
Ca2+ ionophore (A23187), 5 pM thapsigargin (Tg) or buffer. Inset for B: 
Zoomed-in look at the lack of ATP release caused by thapsigargin, A23187, 
and buffer. 
Figure 4. Phospholipase C dependence of compound 48/80-induced release of ATP 
from HUVECs. HUVECs were pretreated for 20 min with either the PLC 
inhibitor U73122 (10 jxM) or its inactive analog U73343 (10 pM). Removal 
of extracellular Ca2+ by pretreatment in Ca2+-free buffer containing 100 |xM 
EGTA was performed concurrently with 10 JIM U73122 (U73122/EGTA) to 
further investigate the role of PLC on release of ATP. Representative time 
courses of ATP release (A) and Ca2+ signaling (C) are depicted along with 
plots of overall ATP release (B) and Ca2+ signaling (D) for cells stimulated 
with 15 pg/ml compound 48/80. 
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Figure 5. Protein kinase C-dependence of compound 48/80-induced release of ATP 
from HUVECS. HUVECs were pretreated for 30 min with 5 jiM BIM andl 
(J,M Go6893, both PKC inhibitors (A and B), or with 1 JJM PMA or 1 PM 
indolactam V (Indo), both PKC activators (C and D). Representative time 
courses of ATP release (A and C) are depicted along with plots of overall 
ATP release (B and D) for cells stimulated with 15 pg/ml compound 48/80. 
Figure 6. Nitric oxide-dependence of compound 48/80-induced release of ATP from 
HUVECS. HUVEC dishes were pretreated for 30 min with either 100 (jM IG­
NAME, 10 |iM L-NMMA, or buffer. Representative time courses of ATP 
release (A) are depicted along with plots of overall ATP release (B) for cells 
stimulated with 15 pg/ml compound 48/80. 
Figure 7. Glybenclamide pretreatment does not perturb compound 48/80-induced 
release of ATP form HUVECs. HUVECs were treated with 100 |xM 
glybenclamide (Glyb) or buffer prior to stimulation with 15 pg/ml compound 
48/80. Representative time courses of ATP release (A) are depicted along 
with plots of overall ATP release (B). 
44 
42 sec 
FIGURE 1A 
45 
700 
600 
500 
400 I | 
a. 3oo 
200 
100 
2 4 12 0 
Time (min) 
FIGURE IB 
46 
5 
4.5 
4 
3.5 
3 
2.5 
2 
1.5 
1 
0.5 
0 
20 30 40 80 0 10 50 60 70 
Concentration of Compound 48/80 (^g/ml) 
FIGURE 1C 
47 
buffer 
/ 
Mastoparan 
o 20 
20 40 60 80 100 120 140 160 180 
Time (s) 
FIGURE 2A 
48 
buffer PTX 
Condition 
mastoparan 
FIGURE 2B 
FIGURE 3A 
50 
100.00 
90.00 
0 80.00 
§ 
g 70.00 
1 60.00 
I 
JS 50.00 
O 
H 40.00 
< 
| 30.00 
75 
Ê 20.00 
10.00 
0.00 -
0 20 40 60 80 100 120 140 160 
Time (s) 
Inset: 
q48/80 ^.Tg/EGTA 
2 -
1 -
n -
,Tg I — A23187 a— r buffer— 
0 50 100 150 
23187 
buffer 
Tg/EGTA 
FIGURE 3B 
51 
100 
<D 
û- ë 75 h œ 
i l -
' i .  
48/80 Tg/EGTA buffer A23187 Tg 
Condition 
FIGURE 3C 
52 
48/80 1200 
A23187 
3 1000 
800 
600 
u-
n 
200 
0 
50 100 0 150 
Time (s) 
FIGURE 3D 
53 
100 
buffer A23187 
Condition 
FIGURE 3E 
Normalized ATP Chemilum. (counts) 
55 
120 
U73343 U73122 
Condition 
U73122/EGTA 
FIGURE 4B 
§ 
o 
Calcium/fluo-3 Fluorescence (counts) 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 
57 
U73343 U73122 U73343/EGTA U73122/EGTA 
Condition 
FIGURE 4D 
58 
buffer 
Time (s) 
FIGURE 5A 
59 
120 
S  
g 100 
I  
c 
80 
n •= 60 
II40 
.e O 20 
buffer BIM 
Condition 
Go 6893 
FIGURE 5B 
Normalized ATP Chemiiuminescence 
§ 
r! | l  
Q. 
61 
® 100 
ndo V 
Condition 
FIGURE 5D 
62 
buffer 
L-NAME 
Time (s) 
FIGURE 6A 
63 
120 
buffer L-NAME L-NMMA 
Condition 
FIGURE 6B 
64 
Glybenclamid 
buffer 
100 150 
Time (s) 
FIGURE 7A 
65 
125 
100 
8 
- c 
il 
I! 
75 
50 
O 25 
buffer glybenclamide 
Condition 
FIGURE 7B 
66 
CHAPTER 3. MONITORING REAL-TIME RELEASE OF ATP FROM 
MOLLUSCAN CENTRAL NERVOUS SYSTEMS 
A manuscript prepared for submission to Analytical Chemistry 
Jason A. Gruenhagen*, Peter Lovell, Leonid L. Moroz, and Edward S. Yeung 
* Primary researcher and author 
ABSTRACT 
The further understanding of neuronal function is imperative for the prevention and 
treatment of neurofunctional disorders. To aid in this realization, novel methods for 
monitoring neuronal cell function must be developed and characterized. In this study, we 
report the application of real-time imaging of luciferase-catalyzed ATP bioluminescence for 
the investigation of ATP release from whole central nervous systems of the freshwater snail 
Lymnaea stagnalis. The large neurons of invertebrates, such as Lymnaea, are excellent 
models for the study of general neurobiology. Release of ATP from Lymnaea ganglia varied 
among the different ganglia as well as within individual ganglia. Furthermore, the magnitude 
of ATP release varied following the stimulation of neurons with common neurotransmitters. 
INTRODUCTION 
Neurotransmission is perhaps the most important and most complex of all cell 
processes. Proper neuron function depends not only on the physiology of the neurons 
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themselves, but also on the maintenance of the correct neuronal environment by glial cells 
and endothelial cells. Furthermore, great heterogeneity exists in the neuronal population 
themselves. Various neurons respond to and release numerous neurotransmitters, including 
glutamate, serotonin, catecholamines, dopamine, and several peptide transmitters1"2. 
Additionally, the response of different neurons to these neurotransmitters can vary in both 
magnitude and temporal kinetics. The importance of neurotransmission is further 
exemplified by the variety of pathological disorders that involve improper brain homeostasis, 
including Parkinson's disease, Alzheimer's disease, multiple sclerosis, epilepsy, meningitis, 
and focal cerebral ischemia (strokes)2. Clearly, further understanding of the neuronal 
environment and neurotransmission will yield additional knowledge and superior prevention 
and treatment methodologies for these disorders. 
Traditionally, lesser organisms are utilized in the investigation of neuronal function. 
These model systems are employed because they typically contain fewer neurons resulting in 
less complex neuronal circuits1. Mollusks are especially valuable in this regard. Mollusks 
lack a central brain, instead possessing several masses of neurons, termed ganglia. Within 
these ganglia, the large cell bodies (up to 150 |xm in diameter) of individual neurons can be 
reliably identified from one preparation to the next. This enables the functional 
characterization of specific neurons in a variety of neuronal circuits such that individual 
neurons can be correlated with whole animal behavior output. Furthermore, their large size 
and surface location in the ganglia allow for relatively straightforward removal of individual 
neurons from the ganglia and placement in primary cell culture where the cells exhibit robust 
outgrowth and synaptogenesis 
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Conventionally, radioligand binding, in situ hybridization histochemistry, Western 
blotting, and electrophysiology have been the most common techniques employed for the 
investigation of neuronal function3. While these techniques are extremely valuable, each 
maintains significant shortcomings. For instance, radioligand binding, in situ hybridization, 
and Western blotting allow for sensitive and specific direct detection of macromolecules, but 
lack the temporal resolution to study cells in real-time. Conversely, electrophysiology 
techniques yield real-time results through the measure of ion flux across membranes, but 
cannot yield significant spatial information of signals. Recently, analytical chemists as well 
as neuroscientists have recognized the vast potential for development of techniques for 
application in neuroscience. Typically, these methods are aimed at the detection of 
neurotransmitters in real-time with superior specificity. Current in vivo techniques include 
amperometric detection of dopamine and catecholamines release with carbon-fiber 
electrodes4"6; laser-induced fluorescence detection of amine-containing neurotransmitters 
sampled via microdialysis and separated with liquid chromatography7"8; amperometric 
detection of amine-containing neurotransmitters sampled via microdialysis and separated 
with capillary liquid chromatography9; MALDI-MS detection of peptides and proteins 
separated by CE10"12; and electrochemical detection of dopamine via both direct sampling 
with CE and detection at the cell body with microelectrodes13. Our own group has focused 
on the native fluorescence detection of release and uptake of serotonin14"16. These studies 
were performed on a microscope equipped with a CCD camera yielding superior spatial 
resolution, sensitivity, selectivity, and temporal resolution, simultaneously. With the 
development of the intensified CCD camera, detection of lesser optical signals has become 
possible. For instance, release of catecholamines from chromaffin cells was monitored by 
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capillary electrophoresis with laser induced fluorescence detection17. More recently, a 
method for the real-time detection of bioluminescence generated from the reaction of 
luciferin and ATP in the presence of firefly luciferase was developed in our group18. 
ATP has been identified as an important messenger in the neuronal environment. It is 
released from neurons simultaneously with other neurotransmitters and acts as both a fast 
transmitter and a neuromodulator19"25. Thus, application of our ATP detection technique, 
which has to date only been employed with cultured astrocytes and endothelial cells, to 
detection of ATP release in neuronal systems seemed feasible. Here we investigated the 
figures of merit for our ATP imaging for use in whole mollusk ganglia imaging. Next we 
present the detection of ATP released from the ganglia of the freshwater snail Lymnaea 
stagnalis. Release is assessed spatially within the organism and individual ganglia. Finally, 
we evaluate the effect of artificial neurotransmitter stimulation on release of ATP from 
Lymnaea. 
EXPERIMENTAL SECTION 
Chemicals. Firefly luciferase (from Photinus pyralis )  w a s  o b t a i n e d  f r o m  R & D  
Systems (Minneapolis, MN). NOC-18 and diethylamine-NONOate (DEA-NONOate) were 
purchased from Calbiochem (La Jolla, CA). All other chemicals were from Sigma (St. 
Louis, MO). Low ionic strength HEPES buffer contained 10 mM 4-(2-hydroxyethyl)-l-
piperazineethanesulfonic acid (HEPES), 5 mM KC1, and 5 mM NaCl (pH = 7.75). Lymnaea 
HEPES buffer contained 10 mM HEPES, 40 mM NaCl, 1.7 mM KC1, 4.1 CaCl2, and 1.5 mM 
MgClz (pH = 7.75). 
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Specimen Preparation. Individual Lymnaea stagnalis (Gastropoda, Pulmonata, 
Basommatophora, Lymnaeidae) were acquired from an inbred population originally raised at 
the Free University Amsterdam. These animals were maintained in well aerated fresh water 
aquaria at room temperature and fed lettuce every other day. Animals with shell lengths of 
20-30 mm were deshelled with small scissors and anesthetized for 10 minutes in 10% 
Listerine (v/v) solution in Lymnaea HEPES buffered saline. Animals were pinned down 
under saline in black sylgard dissection dishes and the ganglia were removed via a dorsal 
midline incision. Ganglia were pinned down on sylgard dishes under Lymnaea HEPES 
buffered saline and used for subsequent experiments. 
ATP Imaging. ATP imaging was performed on the stage of a stereo dissection 
microscope (Nikon SMZ-2T). Bioluminescence signal was collected through the 1.6X 
objective lens_and detected with an intensified charge-coupled device (iCCD; EEV 576 x 384 
pixels CCD chip, Roper Scientific, Trenton, NJ) attached to the camera mount of the 
microscope. Samples were incubated in 1 ml buffer containing 100 fJ-g/ml firefly luciferase 
and 205 pM o-luciferin. Images were collected at a frequency of 0.80 Hz with 1000 ms 
exposure times. All experiments were performed at room temperature. Stimulants were 
applied to the cells via a micropipette just prior to data acquisition. 
Data Presentation/Analysis. Bioluminescence signal was obtained and processed 
with Winview32 software (Roper Scientific). The number of pixels over a threshold value 
was calculated for each frame of data. The ATP concentrations were determined from a 
calibration curve obtained with the exact same imaging parameters. Standard errors were 
determined for each condition based on the number of samples analyzed. A P value of 
<0.05 was considered significant as calculated by the Student's t-test for paired experiments. 
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RESULTS AND DISCUSSION 
Assessing ATP Imaging for Investigation of Mollusk Neurotransmission. We 
originally aimed to employ the giant sea slug, Aplysia californica, for investigation of release 
of ATP from mollusk ganglia. Aplysia neurons are very large (50 - 500 pm in diameter) 
compared to human neurons (<10 fim in diameter)26. Thus, these neurons would be ideal to 
establish whether ATP is released in neuronal environments. However, upon monitoring 
bioluminescence from ATP standards for luciferase contained in filtered seawater, we noted 
that the detection limit for ATP under these conditions was poor compared to our previous 
experiments. This results because the luminescence efficiency of the luciferase enzyme is 
reduced in solutions containing high salt content, especially Ca2+ ions27. Another plausible 
model mollusk, Lymnaea stagnalis, is a freshwater organism and therefore requires a buffer 
with much lower ionic strength than filtered seawater. Lymnaea neurons are slightly smaller 
(50 - 100 pm in diameter26) than those of Aplysia but are large enough to be applicable for 
this study. To identify which system would yield the best detection efficiency for ATP, we 
compiled calibration curves for bioluminescence detection of ATP in filtered seawater, a 
lower ionic strength balanced salt solution (Lymnaea HEPES buffer), and a low ionic 
strength HEPES buffer containing only MgCl% and NaCl. The low ionic strength HEPES 
buffer has been shown to give the best sensitivity for detection of ATP in our systems. As 
portrayed in Figure 1, Lymnaea HEPES buffer was a much better buffer for ATP detection 
than filtered seawater, but was slightly inferior to low ionic strength HEPES buffer. Because 
of the better sensitivity, we chose to utilize freshwater Lymnaea ganglia throughout this 
study. 
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We next examined whether any of the compounds potentially present in the Lymnaea 
sample would interfere with our ATP detection reaction. Cytidine 5'-triphosphate, guanosine 
5'-triphosphate, uridine 5'-triphosphate, and adenosine 5'-diphosphate (ADP) are all present 
in high concentrations in cells along with ATP28. If any of these compounds either reduced 
ATP bioluminescence or produced bioluminescence themselves, our method would be 
compromised. However, none of these compounds diminished the signal produced by 
injection of ATP standards. Furthermore, of these chemicals, only ADP caused any 
significant signal of its own in the presence of luciferin and luciferase. The signal from ADP 
was over two orders of magnitude smaller than that caused by the same concentration of 
ATP. Additionally, nitrites and nitrates are also prevalent in molluscan nervous systems29. 
However, neither of these anions either caused bioluminescence itself or inhibited ATP 
bioluminescence. Additionally, mollusks ganglia contain numerous nitrergic neurons, which 
produce large amounts of nitric oxide (NO, 100 nM)26. To identify whether NO could 
interfere with our detection scheme we employed the NO donors, DEA-NONOate and NOC-
18. DEA-NONOate, but not NOC-18, caused slight bioluminescence in standard 
experiments. A large concentration of NO was necessary to cause even a minute signal, and 
thus its interference was not considered significant. Finally, interference from the 
neurotransmitters employed as stimulants later in this study was assessed. Neither serotonin 
nor KC1 caused bioluminescence in the presence of luciferin and luciferase. Likewise neither 
compound reduced the ability of ATP to produce bioluminescence. Thus, ATP imaging was 
satisfactory for use in the investigation of Lymnaea neurotransmission. 
Release of ATP from the Lymnaea CNS. Through careful dissection of Lymnaea, a 
complete and functional central nervous system (CNS) can be isolated. When bathed in ATP 
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imaging solution immediately following isolation from the organism, all ganglia of the 
Lymnaea CNS release large amounts of ATP. Several studies have previously shown that 
glia cells release ATP when physically stimulated18' 30~32. This is likely the source for much 
of the observed ATP. As expected, the amount of ATP signal, and thus ATP release, from 
the sample decreased with time. After a period ofVi -1 hour the release of ATP from the 
CNS leveled off. Figure 2 (A and B) depict release of ATP from an isolated CNS four hours 
after its dissection and isolation, while Figure 2 (C and D) show release from the right pedal 
ganglion under higher magnification. This ATP signal persisted for over eight hours (the 
longest time that release was monitored from a single specimen). ATP release from 
physically stimulated astrocytes diminishes on the order of minutes18, suggesting that this 
extended release is associated with the neurons. Moreover, ATP release due to damaged or 
dead cells within the CNS would not likely be sustained nor would it remain stable for such a 
time period. Further evidence that ATP release from the Lymnaea CNS was authentic and 
not from cell damage was obtained from electrophysiology experiments. Isolated neurons 
were bathed in ATP detection solution while the membrane potential was monitored via a 
sharp intracellular electrode. Neither luciferin nor luciferase had any effect on membrane 
potential or on the ability to fire action potentials following depolarization (n=4 neurons, data 
not shown). These electrophysiological responses require the presence of stable and 
functional membranes and thus verify that release of ATP from the Lymnaea CNS is a 
natural event. Furthermore, to check that neurons are excited (depolarized) in response to 
serotonin or K+ perfusion, membrane potential was monitored during the application of these 
compounds. Both serotonin and high K+ depolarized the neurons and caused the firing of 
action potentials. 
Spatially Isolated Release of ATP. Release from the right pedal ganglion of a 
Lymnaea CNS in Figure 2 (C and D) appeared to be limited spatially. Hence, we sought to 
identify if this was an isolated case or a general trend. Upon examination of other specimens, 
we found that release was not uniform, but varied within the ganglion in all cases. This was 
most evident in the visceral ganglion. Figure 3 (A and D) show two visceral ganglia from 
distinct Lymnaea specimens. The detected release of ATP from these ganglia is shown in 
Figure 3 (B and E). In both of these ganglia, a large amount of ATP is being released from a 
specific region within the specimen, while other regions of the sample display very little 
signal. Figure 3 (C and F) further illustrate this phenomenon by depicting the calculated 
ATP release for regions of high release, low release, and background. It is interesting that 
the releasing regions of both ganglia are in similar positions in the samples. However, 
without single cell resolution on our optical images, it is impossible to conclude whether 
release in both cases is coming from the same few or single cell. 
Induced ATP Release via Addition of Neurotransmitters. We next sought further 
evidence that the release of ATP observed above was indeed from the neurons. If ATP does 
act as either a neuromodulator or neurotransmitter in Lymnaea, its release should be 
regulated by the activity of the cells. Thus neurotransmitters, which are either excitatory or 
inhibitory in neurons, should influence the amount of ATP released in the Lymnaea CNS. 
We first employed KC1 to stimulate neuron activity. High KC1 solutions depolarize neurons 
by altering the electrochemical gradient across the membrane and are commonly utilized to 
artificially mimic neurotransmitter-induced neuron firing. As depicted in Figure 4 (A - C), 
addition of KC1 escalated release of ATP from the left pedal ganglion of this Lymnaea 
ganglion. Figure 4 (D - G) depict pre- and post-stimulation plots of ATP release from the 
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left pedal ganglion, the visceral ganglion, and a non-ganglion region. Since K+ stimulation 
of neurons was effective in initiating accelerating release of ATP, we sought a more specific 
stimulus to examine. Serotonin was utilized since a number of neurons in the Lymnaea CNS 
are serotonin-sensitive33. As with KC1, serotonin increased the magnitude of ATP release 
when artificially added to the Lymnaea CNS. Figure 5 (A and B) depict an optical image and 
ATP release from a right pedal ganglion. After addition of serotonin, the release of ATP 
from this ganglion was significantly augmented, as shown in Figure 5C. ATP signal plots for 
the pedal ganglion and a non-ganglion area are presented in Figure 5 (D and E) prior to and 
after serotonin addition. The right cerebral ganglion is visible in the extreme left side of 
these images. As displayed in Figure 5F, ATP release from this ganglion is unaffected by the 
addition of serotonin. Furthermore, the right pleural ganglion is visible in the upper left of 
the images and has a slightly enhanced level of ATP release after addition of serotonin. 
Thus, as expected, only particular cells in certain ganglia initiate release of ATP after 
stimulation. 
CONCLUSIONS 
In this report, we have applied our real-time ATP imaging technique to study release 
of ATP in the CNS. The freshwater snail Lymnaea was chosen as our model system because 
of the simplicity of its CNS, the large size of its neurons, and the high sensitivity of ATP 
imaging in Lymnaea buffer. Release from the various ganglia of Lymnaea was detected and 
varied spatially from ganglion to ganglion and within an individual ganglion. Furthermore, 
addition of neuroexcitatory compounds to the sample escalated release of ATP in certain 
regions of the CNS. Future inquiries with this technique involve attempting to identify the 
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specific regions or cells in ATP release and to link ATP release directly to synaptic 
transmission through simultaneous application of imaging and electrophysiology. Clearly, 
with its high spatial resolution, temporal resolution, selectivity, and sensitivity, this technique 
has the potential to further our understanding of neurotransmission. 
ACKNOWLEDGEMENTS 
The authors would like to thank Dr. Jinjian Zheng, Thomas J. Ha, Sami Jezzini, and 
Michaela Bodnarova for their assistance in sample isolation and their helpful discussions. 
The Ames Laboratory is operated for the U. S. Department of Energy by Iowa State 
University under Contract No. W-7405-Eng-82. This work is supported by the Director of 
Science, Office of Basic Energy Sciences, Division of Chemical Sciences. 
REFERENCES 
1. Wall, Z. W. An Introduction to Molecular Neurobiology, Sinauer Assossiates: 
Sunderland, MA, USA, 1992. 
2. Walz, W. ed. The Neuronal Environment: Brain Homeostasis in Health and Disease; 
Humana Press: Totowa, NJ, USA, 2002. 
3. Boulton, A. A., Baker, G. B., Bateson, A. N. eds. In Vitro Neurochemical 
Techniques; Humana Press: Totowa, NJ, USA, 1999. 
4. Hochstetler, S. E., Puopolo, M., Gustincich, S., Raviola, E., Wightman, R. M. "Real­
time amperometric measurements of zeptomole quantities of dopamine released from 
neurons" Anal. Chem. 2000, 72,489-496. 
5. Mundorf, M. L., Joseph, J. D., Austin, C. M., Caron, M. G., Wightman, R. M. 
"Catecholamine release and uptake in the mouse prefrontal cortex" J. Neurochem. 
2001, 79,130-142. 
6. Phillips, P. E., Stuber, G. D., Heien, M. L., Wightman, R. M., Carelli, R. M. 
"Subsecond dopamine release promotes cocaine seeking" Nature 2003,422,614-618. 
7. Zhou, S. Y., Zuo, H., Stobaugh, J. F., Lunte, C. E., Lunte, S. M. "Continuous in vivo 
monitoring of amino acid neurotransmitters by microdialysis smapling with on-line 
derivatization and capillary electrophoresis" Anal. Chem. 1995, 67, 594-599. 
8. Bowser, M. T., Kennedy, R. T. "In vivo monitoring of amine neurotransmitters using 
microdialysis with on-line capillary electrophoresis" Electrophoresis 2001,22,3668-
3676. 
9. McKenzie, J. A., Watson, C. J., Rostand, R. D., German, I., Witowski, S. R., 
Kennedy, R. T. "Automated capillary liquid chromatography for simultaneous 
determination of neuroactive amines and amino acids" J. Chromatogr. A 2002, 962, 
105-115. 
10. Fuller, R. R., Moroz, L. L., Gillette, R., Sweedler, J. V. "Single neuron analysis by 
capillary electrophoresis with fluorescence spectroscopy" Neuron 1998,20,173-181. 
11. Park, Y. H., Zhang, X., Rubakhin, S. S., Sweedler, J. V. "Independent optimization of 
capillary electrophoresis separation and native fluorescence detection conditions for 
indolamine and catecholamine measurements" Anal. Chem. 1999, 71, 4997-5002. 
12. Rubakhin, S. S., Page, J. S., Monroe, B. R., Sweedler, J. V. "Analysis of cellular 
release using capillary electrophoresis and matrix assisted laser desorption/ionization-
time of flight-mass spectrometry" Electrophoresis 2001, 22, 3752-3758. 
78 
13. Anderson, B. B., Ewing, A. G. "Chemical profiles and monitoring dynamics at an 
individual nerve cell in Planorbis comeus with electrochemical detection" J. Pharm. 
Biomed. Anal. 1999,19,15-32. 
14. Tan, W., Parpura, V., Haydon, P. G., Yeung, E. S. "Neurotransmitter imaging in 
living cells based on native fluorescence detection" Anal. Chem. 1995, 67, 2575-
2529. 
15. Lillard, S. J., Yeung, E. S. "Temporal and spatial monitoring of exocytosis with 
native fluorescence imaging microscopy" J. Neurosci. Methods 1997, 75,103-109. 
16. Parpura, V., Tong, W., Yeung, E. S., Haydon, P. G. "Laser-induced native 
fluorescence (LINF) imaging of serotonin depletion in depolarized neurons" J. 
Neurosci. Methods 1998, 82,151-158. 
17. Yeung, E. S. "Following single cell dynamics with native fluorescence microscopy" 
Anal. Chem. 1999, 71, 522A-529A. 
18. Wang, Z., Haydon, P. G., Yeung, E. S. "Direct observation of calcium-independent 
intercellular ATP signaling in astrocytes" Anal. Chem. 2000, 72, 2001-2007. 
19. Wang, Z., Yeung, E. S. "Selective detection of neurotransmitters by fluorescence and 
chemiluminescence imaging" Pure Appl. Chem. 2001, 73, 1599-1611. 
20. von Kugelgen, I., Allgaier, C., Schobert, A., Starke, K. "Co-release of noradrenaline 
and ATP from cultured sympathetic neurons" Neuroscience 1994, 61,199-202. 
21. Santos, P. F., Caramelo, O. L., Carvalho, A. P., Duarte, C. B. "Characterization of 
ATP release from cultures enriched in cholinergic amacrine-like neurons" J. 
Neurohiol. 1999, 41, 340-348. 
79 
22. Brown, P., Dale, N. "Spike-independent release of ATP from Xenopus spinal neurons 
evoked by activation of glutamate receptors" J. Physiol. 2002, 540, 851-860. 
23. Jo, Y. H., Role, L. W. "Coordinate release of ATP and GABA at in vitro synapses of 
lateral hypothalamic neurons" J. Neurosci. 2002, 22,4794-4804. 
24. Santos, D. A., Salgado, A. I., Cunha, R. A. "ATP is released from nerve terminals and 
from activated muscle fibres on stimulation of the rat phrenic nerve" Neurosci. Lett. 
2003,338,225-228. 
25. Newman, E. A. "Glial cell inhibition of neurons by release of ATP" J. Neurosci. 
2003,23,1659-1666. 
26. Moroz, L. L. "Giant identified NO-releasing neurons and comparative histochemistry 
of putative nitrergic systems in gastropod mollusks" Microsc. Res. Tech. 2000, 49, 
557-569. 
27. Stanley, P. E., McCarthy, B. J., Smither, R. eds. ATP Luminescence: Rapid Methods 
in Microbiology, Blackwell Scientific: Oxford, UK, 1989. 
28. Tomiya, N., Ailor, E., Lawrence, S. M., Betenbaugh, M. J., Lee, Y. C. 
"Determination of nucleotides and sugar nucleotides involved in protein 
glycosylation by high-performance anion-exchange chromatography: sugar 
nucleotide contents in cultured insect cells and mammalian cells" Anal. Biochem. 
2001 293,129-137. 
29. Cruz, L., Moroz, L. L., Gillette, R., Sweedler, J. V. "Nitrite and nitrate levels in 
individual molluscan neurons: single-cell capillary electrophoresis analysis" J. 
Neurochem. 1997,69,110-115. 
80 
30. Newman, E. A. "Propagation of intercellular calcium waves in retinal astrocytes and 
Muller cells" J. Neurosci. 2001,21,2215-2223. 
31. Verderio, C., Matteoli, M. "ATP mediates calcium signaling between astrocytes and 
microglial cells: modulation by IFN-gamma" J. Immunol. 2001,166,6383-6391. 
32. Stout, C. E., Costantin, J. L., Naus, C. C., Charles, A. C. "Intercellular calcium 
signaling in astrocytes via ATP release through connexin hemichannels" J. Biol. 
Chem. 2002,277,10482-10428. 
33. Walcourt-Ambakederemo, A., Winlow, W. "5-HT receptors on identified Lymnaea 
neurones in culture: pharmacological characterization of 5-HT2 receptors" Gen. 
Pharmacol. 1994,25, 1079-1092. 
81 
34. FIGURE CAPTIONS 
Figure 1. Standard calibration curves for luciferase-catalyzed ATP bioluminescence in 
low ionic strength HEPES buffer (À), Lymnaea HEPES buffer (•), and 
filtered seawater (X). 
Figure 2. Spatially resolved imaging of a Lymnaea CNS using a iCCD. (A) A compiled 
optical image of a whole CNS from 25 individual 100 ms images under low 
room light. (B) A compiled ATP bioluminescence image of the same whole 
CNS from 19 individual 1000 ms images. (C) A higher magnification 
compiled optical image of the right pedal ganglion of a Lymnaea specimen. 
The image is the average of 20 individual 100 ms images under low room 
light. (D) The corresponding compiled ATP bioluminescence image of the 
same ganglion averaged from 25 individual 1000 ms images. 
Figure 3. Spatially limited release of ATP from two visceral ganglia. Compiled optical 
images of visceral ganglia from two individual Lymnaea specimens. The 
images are the average of 20 (A) and 50 (B) individual 100 ms images under 
low room light. The corresponding compiled ATP bioluminescence images of 
the same ganglia averaged from 8 (B) and 20 (E) individual 1000 ms images. 
(C, F) Calculated individual frame ATP release from the outlined areas in A 
and D, respectively. 
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Figure 4. Stimulation of ATP release by addition of K+. (A) Compiled optical image of 
a Lymnaea CNS averaged from 50 individual 100 ms images under low room 
light. Corresponding compiled ATP bioluminescence images from the same 
CNS prior to (B) and following (C) addition 1 mM KC1. Images are the 
average of 8 and 20 individual 1000 ms images of ATP bioluminescence, 
respectively. Calculated ATP release plots from the left pedal ganglion (D), 
visceral ganglion (E), and non-ganglion, background area (F) prior to (•) and 
following (•) stimulation. ATP release plots are calculated for the areas 
outlined in A. 
Figure 5. Stimulation of ATP release by addition of serotonin. (A) Compiled optical 
image of the right pedal ganglion of a Lymnaea CNS averaged from 50 
individual 100 ms images under low room light. Corresponding compiled 
ATP bioluminescence images from the same ganglion prior to (B) and 
following (C) addition of 100 pM serotonin. Images are the average of 25 
individual 1000 ms images of ATP bioluminescence. Calculated ATP release 
plots from the right pedal ganglion (D), non-ganglion, background area (E), 
and right cerebral ganglion (F) prior to (•) and following (•) stimulation. 
ATP release plots are calculated for the areas outlined in A. 
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ABSTRACT 
As the field of nanotechnology continues to expand at an astounding rate, the need for 
techniques for the analysis and characterization of nanoparticles is emerging. This challenge 
can be met through both the development of new techniques and the reapplication of existing 
methods to new systems. We employed adenosine 5-triphosphate (ATP)Zluciferase 
chemiluminescence imaging to study the release of ATP from end-capped mesoporous 
nanospheres. Mesoporous silica nanospheres of the MCM-41 type were bathed in a solution 
of ATP and were end-capped encasing the ATP. The particles were collected and thoroughly 
washed to remove any physisorbed ATP. We monitored the uncapping of these particles 
with disulfide-reducing agents and the subsequent release of the encased ATP via firefly 
luciferase chemiluminescence. Release profiles were compared amongst various capping 
themes and disulfide-reducing agent concentrations. 
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INTRODUCTION 
The field of nanotechnology remains one of the hottest areas in science. Nanoscience refers 
to the ability to build molecular systems, termed nanostructures, on an atom by atom basis. 
A more general definition of nanotechnology is the synthesis and analysis of structures that 
can be understood on the nanometer scale1. Nanoscience has shown great potential in the 
fields of microscale electronics2"4, electro-optics5, biosensors6"9, etc. One particularly 
interesting application of nanostructures is the development of novel drug delivery systems. 
Traditionally, responsive polymer systems have been designed as such devices. Hydogel 
polymers are synthesized in the presence of the drug molecule of interest. The polymer, with 
the drug encapsulated within, usually exhibits very little release of the drug under normal 
conditions. The polymers are designed to be permeable to small molecules, but impermeable 
to the higher molecular weight drug compounds. However, upon stimulation, the hydrogels 
swell and drug flows through the enlarged pores in the polymer. Drug delivery polymers 
have been synthesized to respond to numerous types of stimulants. External stimulants 
include exposure of the polymers to a magnetic field, ultrasound, elevated temperature, and 
electric field. Other self-regulated polymers respond to their local environment with 
increased or decreased rates of drug release (see references 10 & 11 for thorough reviews of 
all of these delivery systems). For instance, Horbett and colleaugues coupled a glucose 
sensor with a pH-sensitive insulin release mechanism. When the concentration of glucose in 
the blood increases, so does its concentration within the polymer. The glucose is broken 
down to gluconic acid by glucose oxidase immobilized within the polymer. The gluconic 
acid lowers the pH of the solution causing swelling of the polymer. Insulin encapsulated 
within the polymer is released through the swelled pores12. 
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A unique type of drug delivery system was developed recently by our collaborators13. 
They synthesized mesoporous silica nanospheres of the MCM-41-type and CdS nanocrystals 
for containing the drug and capping the nanosphere pores, respectively. Model drug 
molecules loaded into the nanosphere pores were released by addition of disulfide bond-
reducing molecules. This type of drug delivery system has numerous advantages over the 
responsive polymers systems. Prior to uncapping, the particles exhibit negligible release of 
the drug because the drug is trapped within the pores of the nanospheres. This feature is 
doubly advantageous: release of the drug would be more site-specific, and just as 
importantly, the drug would be protected from the external environment by the nanosphere. 
Exposure to the air or to antibodies within the body could conceivably damage the drug 
molecule. More recently, new removable caps were synthesized based on dendrimer 
technology. Generation 2.5 and generation 4.5 carboxyl-terminated PAMAM dendrimers, 
which are spherical, are the appropriate size to bind to the pores of the nanospheres and trap 
loaded drug molecules14. 
With the significant advances in drug delivery systems, significant research has been 
conducted on the release mechanisms and kinetics. For example, Lai and colleagues 
monitored the release of encapsulated ATP from their MCM-41-type mesoporous 
nanospheres utilizing high performance liquid chromatography (HPLC)13"14. They assayed 
release of ATP prior to and following addition of DTT. While successful, the HPLC method 
was only sensitive enough to detect ATP release on the hour timescale. Alternatively, they 
deposited their nanospheres on a bed of cultured astrocytes. Upon addition of 
mercaptoethanol (ME), ATP was released from the particles and activated Ca2+ signaling in 
the astrocytes. These experiments demonstrated that the nanospheres were biocompatible 
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and that ATP was released in high enough concentrations to activate the purinergic receptors 
of the astrocytes (EC50 ~ 40 nM)15. However, determination of the exact concentration of 
ATP released and the temporal profile of release were not possible by this method either. 
Detection of release in polymeric systems is commonly accomplished by monitoring 
the response of the organism in which it is implanted11. For instance, insulin release 
polymers can be analyzed by monitoring blood glucose levels. Glucose is injected into 
diabetic and non-diabetic test organisms, usually rats, with and without implanted insulin 
release polymers. The glucose levels are monitored after injection of glucose into the test 
organisms16. However, monitoring release from drug delivery systems on a shorter time 
scale is also of interest. To attain the desired effect of the drug with minimal total drug 
necessary would necessitate complete release of the drug on the millisecond or second 
timescale. Alternatively, other release systems may require continuous release of the drug. 
Thus, methods for the detection of the drug in real-time are indeed desirable. 
ATP detection on a real-time scale is one possible method for just these types of 
analyses. Luciferase catalyzed bioluminescence is a highly sensitive and selective method 
for the detection of ATP. In its assay form, this detection scheme has been widely applied in 
biological fields17. Through use of an intensified charge coupled device (iCCD) attached to a 
microscope, Wang and colleagues demonstrated real-time imaging of release of ATP from 
glial cells with luciferase chemiluminescence detection18. Detection limits of 10"8 M were 
attained for standard solutions of ATP. They detected release of ATP from physically 
stimulated astrocytes. Through simultaneous imaging of intracellular Ca2+ levels along with 
ATP, they were able to study intercellular communication among the cells. More recently, 
real-time ATP imaging has been applied to the investigation of E. coli cell death19, ATP 
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release mechanisms in astrocytes20 and endothelial cells21, and the role of ATP in 
neurotransmission in molluscan neural systems22. This imaging technique possesses 
numerous attributes which would be beneficial for analysis of drug delivery systems: high 
specificity, high sensitivity, excellent temporal response, etc. 
Here we present the utilization of ATP chemiluminescence imaging for monitoring 
the release of ATP from encapsulated MCM-type mesoporous nanospheres. Real-time 
imaging was employed for investigating the magnitude and kinetics of release from the 
particles. 
EXPERIMENTAL SECTION 
Chemicals. Firefly luciferase (from Photinus pyralis )  w a s  o b t a i n e d  f r o m  R & D  
Systems (Minneapolis, MN). ME and tris(2-carboxyethyl)phosphine (TCEP) was purchased 
from Aldrich (Milwaukee, WI). All other chemicals were from Sigma (St. Louis, MO). Low 
ionic strength HEPES buffer contained 10 mM 4-(2-hydroxyethyl)-1 -
piperazineethanesulfonic acid (HEPES), 5 mM KC1, and 5 mM NaCl (pH = 7.75). 
Bioluminescence imaging solution was comprised of low ionic strength HEPES buffer with 
100 (ag/ml firefly luciferase and 205 pM o-luciferin. Half-generation poly(amidoamine) 
(G4.5 PAMAM , supplied as 5 wt.% in methanol) dendrimer was obtained from Aldrich. 3-
mercaptopropyltrimethoxysilane (MPTMS), «-cetyltrimethylammonium bromide (CTAB), 
tetraethyl orthosilicate (TEOS), 2-aminoethanethiol hydrochloride (MEA), l-[3-
(dimethylamino)propyl]-3 -ethylcarbodiimide hydrochloride (EDC), mercaptoethanol (ME), 
tris(2-carboxyethyl) phosphine hydrochloride (TCEP) and aldrithiol-2 were purchased 
(Aldrich) and used as received. Adenosine triphosphate disodium salt (ATP) were obtained 
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from Sigma and used without further purification. Nanopure water (18.1 MHz) prepared 
from a Barnstead E-pure water purification system was employed throughout. PBS buffer 
(10.00 mM, pH 7.4) solutions with the total ionic strength of 0.06 M were prepared and used 
as the solvent for all the loading and release experiments of ATP. 
Loading and Washing of ATP into the Mesoporous Framework of Linker-MSN 
and the Capping of the Mesopores with Mercaptoacetic Acid-Functionalized CdS 
Nanoparticles. MCM-41-type mesoporous silica nanospheres with 2-
(propyldisulfanyl)ethylamine functionality, mercaptoacetic acid-derivatized cadmium sulfide 
(CdS) nanoparticles, and carboxyl-terminated PAMAM dendrimers were synthesized as 
described previously13"14. For loading of the particles, the purified linker-MSN material 
(100.00 mg) was incubated in phosphate-buffered saline (PBS) solution (0.60 mL, pH 7.4) of 
3.00 (amol ATP for 24 h. The mercaptoacetic acid-functionalized CdS nanoparticles (0.15 
mmol) were dissolved in 2.00 mL of PBS buffer with ATP (0.01 mmol in both cases). l-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (57.50 mg, 0.30 mmol) was 
added to the CdS/drug solution. The reaction mixture was allowed to stir for 24 h, followed 
by centrifuging the suspension at 12 000 rpm for 3 min. The resulting precipitates (ATP-
loaded, CdS-capped MSNs) were isolated and dried under vacuum. The CdS-capped MSN 
with ATP (10.00 mg) material was dispersed in 1.50 mL of PBS buffer (pH 7.4), followed by 
repeating wash/sonication/centrifugation cycles for five times to remove physisorbed ATP 
molecules from the exterior surface of the material. Following these washes, the particles 
were again dried under vacuum. 
Loading of ATP into the Mesoporous Framework of Linker-MSN and the 
Capping of the Mesopores with G4.5 PAMAM Dendrimers. The purified linker-MSN 
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material (100.00 mg) was incubated in the aforementioned PBS buffer solution (0.7 mL, pH 
7.4) of ATP (3.00 Fmol) for 24 h. 2 mL of G4.5 Starburst dendrimer solution (supplied as 5% 
w/w in methanol) was evaporated and transferred to lmL aqueous solution in the buffer. 1-
[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) (30 mg) was added to 
the G4.5/drug solution. The reaction mixture was allowed to stir for 24 h. Any remaining 
unreacted dendrimers and by-products were removed by subsequent washing via 
centrifugation, and redispersion of the suspension using water. The resulting precipitates 
(ATP- loaded, G4.5-capped MSNs) were isolated and dried under vacuum. 
Scanning and Transmission Electron Microscopy. Particle morphology of these 
materials was determined by scanning electron microscopy (SEM) using a JEOL 840A 
scanning electron microscope with 10 kV accelerating voltage and 0.005 nA of beam current 
for imaging. For transmission electron microscopy (TEM) studies, a small aliquot was 
removed and placed between two clean glass slides. Slides were rubbed back and forth to 
break up larger clumps. The resulting powder was washed into a Petri dish with acetone. 
The mixture was stirred and ultrasonically agitated. While still in suspension, a lacey 
carbon-coated TEM grid was pulled through the suspension. The grid was allowed to dry in 
air and then examined in an Amray 1845 FE-SEM followed by examination with a Philips 
model CM-30 TEM operated at 300 kV. The specimen was given no further treatment, as it 
appeared stable under beam bombardment. The preparation for the microtomed samples 
included embedding into a derivation of EPON epoxy resin using EmBed 812. This mixture 
was centrifuged and cured for 24 h at 60 ° C. The embedded block was microtomed to 
obtain thin sections of 60-80-nm thickness by using a Reichert Ultracut S ultramicrotome 
with a diamond knife (Diatome). The floated sections were mounted on a 400 mesh Pd-
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coated Cu grid. The TEM images of these microtomed samples were recorded using a 
Philips model CM-30 TEM operated at 300 kV at 69 000 to 340 000 electron optical 
magnification. 
ATP Imaging. ATP imaging was performed on the stage of an inverted microscope 
(Axiovert 100 TV, Zeiss, Germany). Chemiluminescence signal was collected with a Zeiss 
Apochromat 20X microscope objective (NA = 0.75) and detected with an iCCD (EEV 576 x 
384 pixels CCD chip, Roper Scientific, Trenton, NJ) attached to the camera mount of the 
microscope. Nanosphere bulk samples were incubated in imaging solution for at least four 
hours prior to conducting experiments. The nanospheres were centrifuged down and the 
supernatant was replaced with fresh imaging solution. Images were collected at a frequency 
of 0.80 Hz with 1000 ms exposure times. All experiments were performed at room 
temperature. Stimulant was applied to the cells via a micropipettor. 
Data Presentation/Analysis. Chemiluminescence signal was obtained and processed 
with Winview32 software (Roper Scientific). The number of pixels over a threshold value 
was tabulated for each particle and each frame of data. The ATP concentrations were 
calculated from a calibration curve obtained with the exact same imaging parameters. 
Displayed images are the average of 50 frames. 
RESULTS AND DISCUSSION 
Characteristics of MCM-41-type Nanospheres. The synthesized MCM-41-type 
nanospheres employed in this study were identical to those examined in previous reports13"14. 
As shown in Figure 1 A, the particles have an average diameter of 200 nm. One unique 
feature of this particular type of nanosphere preparation is their excellent uniformity. The 
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nanospheres, as depicted in Figure 1 (B and C), have linear pores 2.3 nm in diameter 
traversing their entire length. Few chemical techniques afford the parameters necessary to 
examine release of encapsulated drugs from these particles on the second timescale. Extreme 
sensitivity is essential since very small amounts of drug are released from the particles. 
Moreover, an imaging technique would be preferred because release could be observed for 
single or small aggregates of nanospheres. Fluorescence imaging of release of a model 
compound would be one method that meets these criteria. However, as observed in previous 
studies13, the nanospheres capped with CdS are highly fluorescent throughout the visible 
spectrum. Alternatively, chemiluminescence imaging is nearly as sensitive as fluorescence 
imaging. Furthermore, since no light source is utilized in this case, the fluorescent 
nanoparticles would not be problematic. Chemiluminescent imaging of ATP release was 
chosen for a number of reasons. 1) The method is extremely sensitive since firefly luciferase 
has an extremely high luminescence efficiency of 0.8823. 2) The reaction kinetics of firefly 
luciferase catalyzed ATP chemiluminescence are exceedingly rapid24. 3) The luciferase 
enzyme employed in ATP imaging measures approximately 5.5 X6.5 X 8.1 nmin size25 and 
therefore cannot enter the uncapped pores of the nanospheres. This ensures that any detected 
chemiluminescence must result from release of ATP from the nanospheres. 4) Since 
previous experiments were conducted on ATP release from this system13, comparisons can 
be drawn between the investigations. 
Compatibility of ATP Imaging and MCM-type Nanosphere Drug Release. 
Though detection of ATP via firefly luciferase-catalyzed chemiluminescence is highly 
specific for ATP, experiments were conducted to ensure that the uncapping molecules did not 
interfere with the detection scheme. Disulfide bond cleaving molecules are commonly added 
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to protein solutions to maintain proper disulfide bonding. However, excessive concentrations 
of these agents could diminish the activity of firefly luciferase. This appeared to be the case 
for ME and DTT. As depicted in Figure 2A, the chemiluminescence from injection of a 66 
nM ATP standard was four times lower for luciferase containing 500 jaM ME than for 
luciferase without ME. In previous experiments, 1 mM ME was employed to remove the 
CdS caps from their nanospheres. Thus, it was not a suitable uncapping agent for use with 
our detection scheme. As also illustrated in Figure 2A, addition of 10 mM DTT to luciferase 
imaging solution also caused a significant reduction in chemiluminescence from injected 
ATP standards. In this case, however, the reduction in signal was only by a factor of 2. 
Previous experiments demonstrated that DTT concentrations of 0.1 - 10 mM were effective 
in uncapping the CdS-capped nanospheres13. Therefore, further experiments were conducted 
to determine if lower concentrations of DTT also interfered with detection of ATP. Figure 
2B depicts the results of these experiments. DTT concentrations of 20 mM, 10 mM, and 5 
mM showed progressively less interference with our detection of ATP chemiluminescence. 
Finally, 1 mM DTT did not interfere with our detection scheme significantly, compared to 
imaging solution only. Thus, DTT was employed as the uncapping agent in our initial 
experiments. Based on work by Whitesides and coworkers, TCEP was also examined as a 
possible uncapping agent. TCEP was developed as a softer disulfide bond-cleaving 
molecule26 and thus might be a more suitable uncapping agent than DTT for our experiments. 
As shown in Figure 2A, 5 mM TCEP did not cause any significant interference with 
detection of injected ATP standards. Since only 100 fxM TCEP was necessary to induce 
significant uncapping of the nanospheres14, this compound was applicable for our 
experiments. In Figure 2 A, the control (no uncapping agent present) data serves as a 
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calibration curve for the detection of ATP from luciferase-catalyzed chemiluminescence. 
The limit of detection was calculated to be 0.5 nM ATP, and the signal was linear over three 
orders of magnitude (0.5 - 66 nM ATP; R2 = 0.9997). 
Detection of Release of Encapsulated ATP from CdS-capped MCM-41-type 
Mesoporous Nanospheres. Upon addition of nanospheres containing encapsulated ATP to 
imaging solution, very large chemiluminscence levels were observed. This was a result of 
physisorbed ATP on the surface of the particles, rather than release or leakage from inside 
the pores. The surface of the nanospheres is functionalized with positively-charged 2-
(propyldisulfanyl)ethylamine groups, which likely forms strong electrostatic complexes with 
negatively-charged ATP molecules. Rinsing the particles with a high ionic strength buffer 
resulted in removal of a large portion of the physisorbed ATP (data not shown). This 
corroborated our hypothesis, since higher ionic strength solutions would destabilize the 
electrostatic interactions between ATP and the surface amines. By bathing the nanospheres 
in imaging solution for an extended amount of time (~4 hrs), any remaining physisorbed 
ATP was broken down enzymatically into ADP and phosphate. 
Prior to uncapping with DTT, nanospheres generated no significant ATP release. 
However, upon addition of DTT, significant levels of ATP were released from the particles. 
Figure 3A depicts nine frames of chemiluminescence data obtained from a representative 
experiment. The optical image shows an aggregate of nanospheres in the lower right region 
of the image. In this case, the maximal ATP release was observed 93 sec after stimulation, as 
illustrated in the signal profile in Figure 3B. The magnitude of the ATP signal rose quickly 
in an initial burst and then quickly decreased again. The rate of signal decline slowed greatly 
approximately 3-4 min after stimulation, and the magnitude of release approached pre-
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stimulation levels 8-10 min after stimulation. From this release profile, many observations 
can be drawn. First, as previously observed via HPLC, the majority of the ATP which is 
released is detected in the first hour after stimulation with DTT13. Our results suggest that, in 
fact, the majority of release occurs in the first few min after uncapping. The initial peak in 
the signal likely represents release of a pool of free ATP near the "mouths" of the pores. 
Additionally, the release following the initial burst (3-10 min) is likely associated with 
diffusion of free ATP from the center of the particle through the pores to the extracellular 
solution. Finally, the very low-level release detected by Lai and colleagues over a period of 
days would correspond to release of physisorbed ATP from within the pores. The pores, like 
the nanosphere external surface, are functionalized with 2-(propyldisulfanyl)ethylamine 
groups. Thus, the strong adsorption of ATP within the pores can be expected. 
Comparison of Uncapping of Nanospheres by DTT and TCEP. As TCEP was the 
most compatible reducing agent for use with our detection system, it was also utilized for 
uncapping ATP-loaded nanospheres. While ATP was released in this case as well, 
surprisingly the release magnitude was attenuated while the temporal maximum of release 
was extended compared to stimulation of identical particles with DTT. Table 1 illustrates 
these observations for stimulation of release by 5 mM TCEP and 5 mM DTT. These results 
indicate that TCEP cannot cleave the disulfides bonds securing the CdS endcaps to the 
nanospheres as quickly as can DTT. Many possible explanations can be proposed for this 
phenomenon. First and foremost, the reducing power of DTT is greater than that of TCEP26. 
The rate of disulfide cleavage for the linkers is likely slower for TCEP than DTT. Thus the 
rate of nanocrystal release and the ATP release would be delayed. Another possible 
explanation of this phenomenon is the charge of TCEP. The CdS nanocrystals are derivitized 
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with carboxylic acid moieties and are thus negatively-charged across their entire surface. 
TCEP is also negatively-charged while DTT is neutral. Therefore, DTT can more easily 
diffuse into the nanosphere structure to reach and cleave the disulfide linkers. Also, since 
TCEP is larger than DTT, its diffusion through the CdS nanocrystal caps could be sterically 
hindered. The actual basis for the attenuated release of ATP in the case of TCEP stimulation 
likely is a combination of the above plus additional unidentified reasons. A further 
investigation of the stimulant diffusion and reaction kinetics would be necessary to fully 
explain our observations. 
Effect of DTT Concentration on Release of Encapsulated ATP from 
Nanospheres. Experiments were conducted to examine the effect of varying the 
concentration of uncapping agent on the kinetics and magnitude of release. DTT 
concentrations from 5 pM to 5 mM were added to CdS end-capped mesoporous nanospheres. 
The 5 mM DTT was employed to ensure complete uncapping of the nanospheres, though it 
decreased the luminescence efficiency as demonstrated in Figure 2B. This was compensated 
for by using the calibration curve for imaging solution containing 5 mM DTT to calculate 
ATP concentration. As depicted in Figure 4 A, the temporal maximum of ATP release was 
delayed for lower concentrations of DTT. Intuitively, for high concentrations, a large 
number of DTT molecules are present near the CdS disulfide linkages. However, for low 
concentrations, the free DTT molecules must diffuse to the particles to cause uncapping. 
Figure 4B shows the magnitude of ATP release was also altered with the various 
concentrations of DTT. 5 mM DTT induced release of 32.9 +/-1.6 nM ATP compared to 
only 8.0 +/- 2.9 nM ATP for 5 jxM DTT. Thus the lower concentrations of DTT were unable 
to completely uncap all of the nanosphere pores or, at least, were unable to uncap all of the 
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pores nearly simultaneously. These results corroborate those obtained previously with 
HPLC13. 
Release of ATP from Dendrimer-capped Nanospheres. Release of ATP from 
MCM-41-type mesoporous nanospheres with dendrimer caps was also assessed. Two types 
of PAMAM-based dendrimers (generations 2.5 and 4.5) have been successfully attached to 
the pores of the nanospheres14. When stimulated with 5 mM DTT, release of ATP was 
detected from both nanospheres. The release profiles are displayed in Figure 5 for generation 
2.5 and generation 4.5 dendrimer-capped particles along with the profile previously shown in 
Figure 3B for DTT stimulation. The release profiles for the dendrimer capped particles are 
obviously quite distinct from those of CdS nanocrystal caps. Upon stimulation with DTT, 
the generation 2.5 dendrimer-capped particles showed no immediate release of ATP. Only 
after 20-30 min was a small amount of release observed from the nanospheres. This ATP 
release slowly increased to a maximum approximately 1.5 hours after stimulation and slowly 
decreased back towards baseline levels. For nanospheres with generation 4.5 dendrimer 
caps, release occurred more quickly. ATP signal began 5 min after the addition of DTT, and 
maximum release was observed 11 min after stimulation. For both types of dendrimer-
capped nanospheres, the maximum release of ATP was smaller and the time for the 
maximum release was longer than that of CdS-capped particles. The dendrimer caps are 
more flexible than the CdS nanocrystal caps. After forming one link to the nanosphere, a 
dendrimer can flex slightly and form additional bonds to the mouth of the nanosphere pore. 
Alternatively, the CdS nanocrystals cannot flex and will form fewer bonds to the nanosphere. 
Therefore, more disulfide bonds would need to be broken in order to release the dendrimer 
caps from the nanospheres upon stimulation. Additionally, with more bonds formed, the 
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dendrimer caps would be held tighter to the nanosphere allowing less room for the reducing 
agents to diffuse into the pores to reach the disulfide linkers. In the case of the generation 2.5 
dendrimers, the dendrimers are actually smaller than the 2.3 nm diameter pores of the 
nanospheres. Therefore, these dendrimers could diffuse into and bind to the nanospheres. 
Thus, the pores of nanospheres capped with generation 2.5 dendrimers would be bound by 
more than one capping molecule. This too would decrease the rate of ATP release the 
nanospheres. Upon further examination of Figure 5, it appears that the total released ATP 
from the dendrimer-capped nanospheres is actually greater than that of the CdS-capped 
particles. As observed via TEM images in earlier report13, the capping efficiency for CdS 
nanocrystal caps is much less than 100%. Alternatively, the dendrimer-capped particles have 
a capping efficiency of nearly 100%. This indicates that though the nanospheres were loaded 
with the same concentration of ATP, the dendrimer-capped particles contain more ATP than 
the CdS-capped particles. Thus, more ATP is present to be released upon stimulation with 
DTT. 
CONCLUSIONS 
Real-time imaging of ATP release via luciferase-catalyzed chemiluminescence is a 
highly sensitive and selective method. This technique is widely applicable in biological 
systems because of the widespread distribution of ATP. We have now applied this imaging 
technique to the study of nanoparticles. Drug release from mesoporous nanospheres end-
capped with CdS nanocrystals and PAMAM dendrimers were monitored by loading the 
nanospheres with ATP and inducing its release. The kinetics of release were investigated 
and revealed a pulse-type release from CdS-capped particles upon uncapping. Alternatively, 
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the dendrimer-capped nanospheres release ATP in a more gradual and plateau-like profile. 
Understanding the release mechanisms and release kinetics of these systems will aid in the 
development of more advanced particle designs. The capping molecules can be tuned to 
whether a high concentration, one-time drug release or a lower level, continuous drug release 
treatment is desired. As additional capping molecules and nanosphere drug containers are 
developed, more advanced, applicable, and tunable drug delivery systems will become 
available. 
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Table 1. Characteristics of release of encapsulated ATP from CdS-capped MCM-type 
mesoporous nanospheres for various reducing agents. 
Uncapping Agent Release Maximum (min) Release Maximum (nM ATP) 
5 mM DTT 1.8+/-0.8 32.1+/-9.8 
5 mM TCEP 8.0 +/- 2.3 4.5 +/- 0.8 
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FIGURE CAPTIONS 
Figure 1. MCM-type mesoporous nanosphere images. SEM (A) and TEM (B, C) 
micrographs of the linker-MSN. The MCM-41 type of mesoporous channel 
structure of the nanospheres is visualized with the hexagonally packed light 
dots shown in B. The white lines traversing the entire particle in C are the 
pores, as viewed perpendicular to the pore axis. Also visible is the CdS 
coating the entire perimeter of the particle. The TEM micrographs (300 kV) 
were measured on an ultramicrotomed sample with a section thickness of 60-
80 ran. 
Figure 2. Effect of disulfide-cleaving molecules on chemiluminescence signal. 
Chemiluminescence signal from ATP standards was collected as detailed in 
the experimental section. (A) ATP standards were injected into imaging 
solution containing 5 mM TCEP (X), 10 mM DTT (A), 1 mM ME (•), and 
imaging solution only (•). (B) ATP standards were injected into imaging 
solution containing DTT concentrations of 20 mM (•), 10 mM (A), 5 mM 
(•), 1 mM (•), and 0 mM (X). 
Figure 3. Release of encapsulated ATP from MCM-type mesoporous nanospheres. 
Chemiluminescence signal from ATP release was collected as detailed in the 
experimental section. (A) 1st frame - Optical image of CdS-capped MCM-
type mesoporous nanosphere aggregate. Other frames - Frames of data 
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depicting release of encapsulated ATP from the nanospheres stimulated with 5 
mM DTT at time zero. (B) Time course for release of ATP from (A). 
Figure 4. Effect of uncapping agent concentration on release of encapsulated ATP from 
MCM-type mesoporous nanospheres. Chemiluminescence signal from ATP 
release was collected as detailed in the experimental section. The temporal 
maximum (A) and maximum magnitude (B) of release of encapsulated ATP 
with various concentrations of DTT. 
Figure 5. Release of encapsulated ATP from dendrimer-capped MCM-41 -type 
mesoporous nanospheres. Chemiluminescence signal from ATP release was 
collected as detailed in the experimental section. Plots depict release of 
encapsulated ATP from the nanospheres stimulated with 5 mM DTT at time = 
2 min for generation 2.5 PAMAM dendrimer-capped particles (o), generation 
4.5 PAMAM dendrimer-capped particles (A) and CdS nanocrystal-capped 
particles. 
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CHAPTER 5. GENERAL CONCLUSIONS 
Innumerable potential research opportunities for analysis of ATP exist due to the 
widespread distribution of ATP in biological systems. Bioluminescence imaging of ATP 
exhibits numerous advantages for ATP analysis, including exceptional sensitivity, 
tremendous selectivity for ATP, excellent temporal resolution, and outstanding spatial 
capabilities. This technique is potentially applicable in examining countless biological and 
chemical systems, three of which were discussed within this dissertation. 
First, the mechanism by which the compound 48/80 induces release of ATP from 
human umbilical vein endothelial cells (HUVECs) was elucidated. The various cellular 
pathways were probed with ATP and Ca2+ imaging to understand their involvement in 
release of ATP. The identified mechanism involved the activation of a Gq-type protein and 
phospholipase C and an increase in intracellular Ca2+. The actual release of ATP appeared to 
proceed through the opening of a non-specific cytoplasmic channel. 
The involvement of ATP in cellular communication in the nervous system was also 
investigated. The ganglia of the freshwater snail Lymnaea stagnalis continuously released 
ATP without neuronal stimulation. This release varied amongst the different ganglia and 
within an individual ganglion. Moreover, ATP levels were amplified upon stimulation of the 
ganglia with common neurotransmitters. 
Finally, the release kinetics of model drug delivery systems were examined with 
bioluminescent ATP imaging. ATP was loaded into the pores of CdS-endcapped 
mesoporous nanospheres to act as a model drug. It was released upon uncapping the 
nanospheres with disulfide bond-cleaving molecules. The drug release occurred within the 
first few minutes after addition of the uncapping agents and declined significantly over the 
following 10-15 minutes. However, the magnitude of the initial burst of ATP was reduced 
and the release kinetics were delayed with lower concentrations of applied uncapping agent. 
Future possible applications of this method include its continued application to drug 
delivery studies. This includes not only more advanced end-capped nanosphere systems, but 
also to responsive polymer systems and sol-gels. In biochemistry, the active role of ATP as a 
cell messenger is still under investigation in numerous cell and tissue types. ATP imaging 
can provide insight into the most ambiguous area of these analyses: the sources of 
extracellular ATP. This would be especially important in neuroscience. Our preliminary 
findings in the freshwater snail Lymanea suggest that ATP is actively being released in the 
central nervous system. This release could occur from synaptic vesicles containing only ATP 
or is ATP copackaged with other neurotransmitters. Alternatively, the release is not 
necessarily synaptic. Instead, it could be cytoplasmic as was observed in HUVECs. In that 
case, ATP release could be occurring from the neurons, the astrocytes surrounding them or 
the other cell types (including endothelial cells) within the CNS. As discussed briefly in 
chapter 2, ATP is copackaged with other cellular messengers in exocytotic vesicles. ATP 
imaging could thus be employed as a general technique to monitor exocytosis. This 
application would advance our understanding of synaptic transmission, muscular contraction, 
immune response, and innumerable other cellular processes. The most important role of 
ATP in biological systems is its involvement in cellular energy homeostasis. Thus, imaging 
intracellular ATP levels would yield information on the metabolic state of cells. This could 
yield information in numerous areas, including the effect of infection and the effect of natural 
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and artificial hormones on cellular homeostasis. ATP imaging is a potentially valuable 
technique for investigations in any of these areas. 
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